David Griffith - Publications

Affiliations: 
Chemistry University of Wollongong, Keiraville, New South Wales, Australia 

30/328 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Feitz A, Schroder I, Phillips F, Coates T, Negandhi K, Day S, Luhar A, Bhatia S, Edwards G, Hrabar S, Hernandez E, Wood B, Naylor T, Kennedy M, Hamilton M, ... ... Griffith D, et al. The Ginninderra CH4 and CO2 release experiment: An evaluation of gas detection and quantification techniques International Journal of Greenhouse Gas Control. 70: 202-224. DOI: 10.1016/J.Ijggc.2017.11.018  0.322
2017 Oh Y, Kenea ST, Goo T, Kim G, Chung K, Griffith D, Velacco V, Rhee J, Oh M, Lee H. Characteristics of the Greenhouse Gas Concentration Derived from the Ground-based FTS Spectra at Anmyeondo, Korea Atmospheric Measurement Techniques Discussions. 1-17. DOI: 10.5194/Amt-2017-88  0.365
2017 Bril А, Maksyutov S, Belikov D, Oshchepkov S, Yoshida Y, Deutscher NM, Griffith D, Hase F, Kivi R, Morino I, Notholt J, Pollard DF, Sussmann R, Velazco VA, Warneke T. EOF-based regression algorithm for the fast retrieval of atmospheric CO2 total column amount from the GOSAT observations Journal of Quantitative Spectroscopy & Radiative Transfer. 189: 258-266. DOI: 10.1016/J.Jqsrt.2016.12.005  0.348
2016 Kulawik S, Wunch D, O'Dell C, Frankenberg C, Reuter M, Oda T, Chevallier F, Sherlock V, Buchwitz M, Osterman G, Miller CE, Wennberg PO, Griffith D, Morino I, Dubey MK, et al. Consistent evaluation of ACOS-GOSAT, BESD-SCIAMACHY, CarbonTracker, and MACC through comparisons to TCCON Atmospheric Measurement Techniques. 9: 683-709. DOI: 10.5194/Amt-9-683-2016  0.389
2013 Redding MR, Lewis R, Waller J, Phillips F, Griffith D. Large-chamber methane and nitrous oxide measurements are comparable to the backward lagrangian stochastic method. Journal of Environmental Quality. 42: 1643-51. PMID 25602405 DOI: 10.2134/Jeq2013.05.0200  0.364
2013 Belikov DA, Maksyutov S, Sherlock V, Aoki S, Deutscher NM, Dohe S, Griffith D, Kyro E, Morino I, Nakazawa T, Notholt J, Rettinger M, Schneider M, Sussmann R, Toon GC, et al. Simulations of column-averaged CO2 and CH4 using the NIES TM with a hybrid sigma-isentropic (σ-θ) vertical coordinate Atmospheric Chemistry and Physics. 13: 1713-1732. DOI: 10.5194/Acp-13-1713-2013  0.387
2013 Flores E, Viallon J, Wielgosz R, Fernández T, Rojo A, Ramírez S, Aoki N, Kato K, Jeongsoon L, Moon D, Kim J, Harling A, Milton M, Griffith D, Smeulders D, et al. Final report on Pilot Study CCQM-P110: Study on the accuracy and uncertainty of FT-IR methods calibrated with synthetic spectra for NO2 concentration measurements Metrologia. 50: 8011-8011. DOI: 10.1088/0026-1394/50/1A/08011  0.349
2012 Humphries R, Jenkins C, Leuning R, Zegelin S, Griffith D, Caldow C, Berko H, Feitz A. Atmospheric tomography: A Bayesian inversion technique for determining the rate and location of fugitive emissions Environmental Science and Technology. 46: 1739-1746. PMID 22191809 DOI: 10.1021/Es202807S  0.37
2012 Crisp D, Fisher BM, O'Dell C, Frankenberg C, Basilio R, Bösch H, Brown LR, Castano R, Connor B, Deutscher NM, Eldering A, Griffith D, Gunson M, Kuze A, Mandrake L, et al. The ACOS CO 2 retrieval algorithm - Part II: Global X CO2 data characterization Atmospheric Measurement Techniques. 5: 687-707. DOI: 10.5194/Amt-5-687-2012  0.39
2012 Saito R, Patra PK, Deutscher N, Wunch D, Ishijima K, Sherlock V, Blumenstock T, Dohe S, Griffith D, Hase F, Heikkinen P, Kyrö E, Macatangay R, Mendonca J, Messerschmidt J, et al. Latitude-time variations of atmospheric column-average dry air mole fractions of CO 2 , CH 4 and N 2 O Atmospheric Chemistry and Physics. 12: 5679-5704. DOI: 10.5194/Acpd-12-5679-2012  0.323
2012 Saito R, Patra PK, Deutscher N, Wunch D, Ishijima K, Sherlock V, Blumenstock T, Dohe S, Griffith D, Hase F, Heikkinen P, Kyrö E, Macatangay R, Mendonca J, Messerschmidt J, et al. Technical Note: Latitude-time variations of atmospheric column-average dry air mole fractions of CO 2 , CH 4 and N 2 O Atmospheric Chemistry and Physics. 12: 7767-7777. DOI: 10.5194/Acp-12-7767-2012  0.38
2012 Oshchepkov S, Bril A, Yokota T, Morino I, Yoshida Y, Matsunaga T, Belikov D, Wunch D, Wennberg P, Toon G, O'Dell C, Butz A, Guerlet S, Cogan A, Boesch H, ... ... Griffith D, et al. Effects of atmospheric light scattering on spectroscopic observations of greenhouse gases from space: Validation of PPDF-based CO2 retrievals from GOSAT Journal of Geophysical Research Atmospheres. 117. DOI: 10.1029/2012Jd017505  0.394
2011 Chevallier F, Deutscher NM, Conway TJ, Ciais P, Ciattaglia L, Dohe S, Frhlich M, Gomez-Pelaez AJ, Griffith D, Hase F, Haszpra L, Krummel P, Kyr E, Labuschagne C, Langenfelds R, et al. Global CO2 fluxes inferred from surface air-sample measurements and from TCCON retrievals of the CO2 total column Geophysical Research Letters. 38. DOI: 10.1029/2011Gl049899  0.381
2011 Butz A, Guerlet S, Hasekamp O, Schepers D, Galli A, Aben I, Frankenberg C, Hartmann JM, Tran H, Kuze A, Keppel-Aleks G, Toon G, Wunch D, Wennberg P, Deutscher N, ... Griffith D, et al. Toward accurate CO2 and CH4 observations from GOSAT Geophysical Research Letters. 38. DOI: 10.1029/2011Gl047888  0.322
2011 Haverd V, Cuntz M, Griffith D, Keitel C, Tadros C, Twining J. Measured deuterium in water vapour concentration does not improve the constraint on the partitioning of evapotranspiration in a tall forest canopy, as estimated using a soil vegetation atmosphere transfer model Agricultural and Forest Meteorology. 151: 645-654. DOI: 10.1016/J.Agrformet.2011.02.005  0.35
2010 Deutscher NM, Griffith DWT, Bryant GW, Wennberg PO, Toon GC, Washenfelder RA, Keppel-Aleks G, Wunch D, Yavin Y, Allen NT, Blavier JF, Jiménez R, Daube BC, Bright AV, Matross DM, et al. Total column CO2 measurements at Darwin, Australia - Site description and calibration against in situ aircraft profiles Atmospheric Measurement Techniques. 3: 947-958. DOI: 10.5194/Amt-3-947-2010  0.399
2010 Houweling S, Aben I, Breon F-, Chevallier F, Deutscher N, Engelen R, Gerbig C, Griffith D, Hungershoefer K, Macatangay R, Marshall J, Notholt J, Peters W, Serrar S. The importance of transport model uncertainties for the estimation of CO2 sources and sinks using satellite measurements Atmospheric Chemistry and Physics. 10: 9981-9992. DOI: 10.5194/Acp-10-9981-2010  0.377
2010 Paton-Walsh C, Deutscher NM, Griffith DWT, Forgan BW, Wilson SR, Jones NB, Edwards DP. Trace gas emissions from savanna fires in northern Australia Journal of Geophysical Research Atmospheres. 115. DOI: 10.1029/2009Jd013309  0.346
2009 Frankenberg C, Yoshimura K, Warneke T, Aben I, Butz A, Deutscher N, Griffith D, Hase F, Notholt J, Schneider M, Schrijver H, Röckmann T. Dynamic processes governing lower-tropospheric HDO/H2O ratios as observed from space and ground. Science (New York, N.Y.). 325: 1374-7. PMID 19745148 DOI: 10.1126/Science.1173791  0.314
2009 Dupuy E, Walker KA, Kar J, Boone CD, McElroy CT, Bernath PF, Drummond JR, Skelton R, McLeod SD, Hughes RC, Nowlan CR, Dufour DG, Zou J, Nichitiu F, Strong K, ... ... Griffith D, et al. Validation of ozone measurements from the Atmospheric Chemistry Experiment (ACE) Atmospheric Chemistry and Physics. 9: 287-343. DOI: 10.5194/Acp-9-287-2009  0.343
2009 Loh Z, Leuning R, Zegelin S, Etheridge D, Bai M, Naylor T, Griffith D. Testing Lagrangian atmospheric dispersion modelling to monitor CO2 and CH4 leakage from geosequestration Atmospheric Environment. 43: 2602-2611. DOI: 10.1016/J.Atmosenv.2009.01.053  0.386
2009 Haverd V, Leuning R, Griffith D, Gorsel Ev, Cuntz M. The Turbulent Lagrangian Time Scale in Forest Canopies Constrained by Fluxes, Concentrations and Source Distributions Boundary-Layer Meteorology. 130: 209-228. DOI: 10.1007/S10546-008-9344-4  0.362
2008 Mahieu E, Duchatelet P, Demoulin P, Walker KA, Dupuy E, Froidevaux L, Randall C, Catoire V, Strong K, Boone CD, Bernath PF, Blavier J-, Blumenstock T, Coffey M, Mazière Md, ... Griffith D, et al. Validation of ACE-FTS v2.2 measurements of HCl, HF, CCl 3 F and CCl 2 F 2 using space-, balloon- and ground-based instrument observations Atmospheric Chemistry and Physics. 8: 6199-6221. DOI: 10.5194/Acp-8-6199-2008  0.379
2008 Loh Z, Chen D, Bai M, Naylor T, Griffith D, Hill J, Denmead T, McGinn S, Edis R. Measurement of greenhouse gas emissions from Australian feedlot beef production using open-path spectroscopy and atmospheric dispersion modelling Australian Journal of Experimental Agriculture. 48: 244-247. DOI: 10.1071/Ea07244  0.361
2007 Mazière MD, Vigouroux C, Bernath PF, Baron P, Blumenstock T, Boone C, Brogniez C, Catoire V, Coffey M, Duchatelet P, Griffith D, Hannigan J, Kasai Y, Kramer I, Jones N, et al. Validation of ACE-FTS v2.2 methane profiles from the upper troposphere to the lower mesosphere Atmospheric Chemistry and Physics. 8: 2421-2435. DOI: 10.5194/Acp-8-2421-2008  0.379
2007 Höpfner M, Von Clarmann T, Fischer H, Funke B, Glatthor N, Grabowski U, Kellmann S, Kiefer M, Linden A, Milz M, Steck T, Stiller GP, Bernath P, Blom CE, Blumenstock T, ... ... Griffith D, et al. Validation of MIPAS ClONO2 measurements Atmospheric Chemistry and Physics. 7: 257-281. DOI: 10.5194/Acp-7-257-2007  0.36
2006 Griffith DW, Jamie I, Esler M, Wilson SR, Parkes SD, Waring C, Bryant GW. Real-time field measurements of stable isotopes in water and CO2 by Fourier transform infrared spectrometry. Isotopes in Environmental and Health Studies. 42: 9-20. PMID 16500751 DOI: 10.1080/10256010500503098  0.602
2006 Notholt J, Toon G, Jones N, Griffith D, Warneke T. Spectral line finding program for atmospheric remote sensing using full radiation transfer Journal of Quantitative Spectroscopy & Radiative Transfer. 97: 112-125. DOI: 10.1016/J.Jqsrt.2004.12.025  0.327
2005 Dils B, Mazière MD, Blumenstock T, Buchwitz M, Beek RD, Demoulin P, Duchatelet P, Fast H, Frankenberg C, Gloudemans A, Griffith D, Jones N, Kerzenmacher T, Kramer I, Mahieu E, et al. Comparisons between SCIAMACHY and ground-based FTIR data for total columns of CO, CH 4 , CO 2 and N 2 O Atmospheric Chemistry and Physics. 6: 1953-1976. DOI: 10.5194/Acp-6-1953-2006  0.36
2004 Paton‐Walsh C, Jones N, Wilson S, Meier A, Deutscher N, Griffith D, Mitchell R, Campbell S. Trace gas emissions from biomass burning inferred from aerosol optical depth Geophysical Research Letters. 31: 5116-5116. DOI: 10.1029/2003Gl018973  0.34
Low-probability matches (unlikely to be authored by this person)
2018 Sun Y, Palm M, Liu C, Hase F, Griffith D, Weinzierl C, Petri C, Wang W, Notholt J. The influence of instrumental line shape degradation on NDACC gas retrievals Atmospheric Measurement Techniques Discussions. 1-35. DOI: 10.5194/Amt-2017-382  0.288
2017 Patra PK, Crisp D, Kaiser JW, Wunch D, Saeki T, Ichii K, Sekiya T, Wennberg PO, Feist DG, Pollard DF, Griffith DWT, Velazco VA, De Maziere M, Sha MK, Roehl C, et al. The Orbiting Carbon Observatory (OCO-2) tracks 2-3 peta-gram increase in carbon release to the atmosphere during the 2014-2016 El Niño. Scientific Reports. 7: 13567. PMID 29051612 DOI: 10.1038/S41598-017-13459-0  0.287
2017 Flores E, Viallon J, Moussay P, Griffith DW, Wielgosz RI. Calibration strategies for FTIR and other IRIS instruments for accurate δ13C and δ18O measurements of CO2 in air. Analytical Chemistry. PMID 28199097 DOI: 10.1021/acs.analchem.6b05063  0.276
2012 Stavrakou T, Müller JF, Peeters J, Razavi A, Clarisse L, Clerbaux C, Coheur PF, Hurtmans D, De Mazière M, Vigouroux C, Deutscher NM, Griffith DWT, Jones N, Paton-Walsh C. Satellite evidence for a large source of formic acid from boreal and tropical forests Nature Geoscience. 5: 26-30. DOI: 10.1038/Ngeo1354  0.275
2013 Oshchepkov S, Bril A, Yokota T, Wennberg PO, Deutscher NM, Wunch D, Toon GC, Yoshida Y, O'Dell CW, Crisp D, Miller CE, Frankenberg C, Butz A, Aben I, Guerlet S, ... ... Griffith D, et al. Effects of atmospheric light scattering on spectroscopic observations of greenhouse gases from space. Part 2: Algorithm intercomparison in the GOSAT data processing for CO2 retrievals over TCCON sites Journal of Geophysical Research: Atmospheres. 118: 1493-1512. DOI: 10.1002/Jgrd.50146  0.267
2022 Wu C, Trounce H, Dunne E, Griffith DWT, Chambers SD, Williams AG, Humphries RS, Cravigan LT, Miljevic B, Zhang C, Wang H, Wang B, Ristovski Z. Atmospheric concentrations and sources of black carbon over tropical Australian waters. The Science of the Total Environment. 159143. PMID 36195151 DOI: 10.1016/j.scitotenv.2022.159143  0.253
2011 Wunch D, Toon GC, Blavier JF, Washenfelder RA, Notholt J, Connor BJ, Griffith DW, Sherlock V, Wennberg PO. The total carbon column observing network. Philosophical Transactions. Series a, Mathematical, Physical, and Engineering Sciences. 369: 2087-112. PMID 21502178 DOI: 10.1098/Rsta.2010.0240  0.248
2008 Griffith DW, Bryant GR, Hsu D, Reisinger AR. Methane emissions from free-ranging cattle: comparison of tracer and integrated horizontal flux techniques. Journal of Environmental Quality. 37: 582-91. PMID 18396544  0.248
2017 Waring CL, Hankin SI, Griffith DWT, Kertesz MA, Kobylski V, Wilson NL, Coleman NV, Kettlewell G, Zlot R, Bosse M, Bell G. Seasonal total methane depletion in limestone caves. Scientific Reports. 7: 8314. PMID 28814720 DOI: 10.1038/S41598-017-07769-6  0.229
2012 Crisp D, Fisher BM, O'Dell C, Frankenberg C, Basilio R, Bösch H, Brown LR, Castano R, Connor B, Deutscher NM, Eldering A, Griffith D, Gunson M, Kuze A, Mandrake L, et al. The ACOS X CO 2 retrieval algorithm, Part 2: Global X CO 2 data characterization Atmospheric Measurement Techniques Discussions. 5: 1-60. DOI: 10.5194/Amtd-5-1-2012  0.214
2010 Griffith DW, Parkes SD, Haverd V, Paton-Walsh C, Wilson SR. Absolute calibration of the intramolecular site preference of 15N fractionation in tropospheric N2O by FT-IR spectroscopy. Analytical Chemistry. 81: 2227-34. PMID 19231842 DOI: 10.1021/ac802371c  0.193
2013 Griffith D, Jones W, Escofet X. Patient perspectives on general surgical training International Journal of Surgery. 11: 689. DOI: 10.1016/J.Ijsu.2013.06.547  0.179
2009 Griffith DR, Barnes RT, Raymond PA. Inputs of fossil carbon from wastewater treatment plants to U.S. rivers and oceans. Environmental Science & Technology. 43: 5647-51. PMID 19731657 DOI: 10.1021/Es9004043  0.178
2013 Phillips R, Griffith DW, Dijkstra F, Lugg G, Lawrie R, Macdonald B. Tracking short-term effects of nitrogen-15 addition on nitrous oxide fluxes using fourier-transform infrared spectroscopy. Journal of Environmental Quality. 42: 1327-40. PMID 24216411 DOI: 10.2134/jeq2013.02.0067  0.178
2016 Sun J, Bai M, Shen J, Griffith DW, Denmead OT, Hill J, Lam SK, Mosier AR, Chen D. Effects of lignite application on ammonia and nitrous oxide emissions from cattle pens. The Science of the Total Environment. 565: 148-154. PMID 27161136 DOI: 10.1016/j.scitotenv.2016.04.156  0.173
2013 Jones D, Al-Momani H, Griffith D, Lewis W, Havard T, Escofet X. Lymphovascular invasion is a histological marker associated with poor survival in oesophageal cancer International Journal of Surgery. 11: 721. DOI: 10.1016/J.Ijsu.2013.06.717  0.17
2023 Metz EM, Vardag SN, Basu S, Jung M, Ahrens B, El-Madany T, Sitch S, Arora VK, Briggs PR, Friedlingstein P, Goll DS, Jain AK, Kato E, Lombardozzi D, Nabel JEMS, ... ... Griffith DWT, et al. Soil respiration-driven CO pulses dominate Australia's flux variability. Science (New York, N.Y.). 379: 1332-1335. PMID 36996200 DOI: 10.1126/science.add7833  0.164
2012 Griffith DR, Wacker L, Gschwend PM, Eglinton TI. Carbon isotopic (13C and 14C) composition of synthetic estrogens and progestogens. Rapid Communications in Mass Spectrometry : Rcm. 26: 2619-26. PMID 23059878 DOI: 10.1002/Rcm.6385  0.146
2024 Cao Y, Bai M, Han B, Butterly C, Hu H, He J, Griffith DWT, Chen D. NH and greenhouse gas emissions during co-composting of lignite and poultry wastes and the following amendment of co-composted products in soil. Environmental Technology. 1-14. PMID 38379449 DOI: 10.1080/09593330.2024.2306799  0.134
2016 Griffith DR, Kido Soule MC, Eglinton TI, Kujawinski EB, Gschwend PM. Steroidal estrogen sources in a sewage-impacted coastal ocean. Environmental Science. Processes & Impacts. PMID 27465804 DOI: 10.1039/C6Em00127K  0.126
2019 Bayliss MAJ, Rigdova K, Kyriakides M, Grier S, Lovering AM, Williams H, Griffith DC, MacGowan A. Development, validation and application of a novel HPLC-MS/MS method for the measurement of minocycline in human plasma and urine. Journal of Pharmaceutical and Biomedical Analysis. 169: 90-98. PMID 30844627 DOI: 10.1016/j.jpba.2019.02.036  0.124
2023 Griffith DR, Carolan M, Gutierrez MM, Romig A, Garcia-Diaz N, Hutchinson CP, Zayas RL. Microbial Degradation of Free and Halogenated Estrogens in River Water-Sediment Microcosms. Environmental Science & Technology. PMID 37428977 DOI: 10.1021/acs.est.3c00801  0.114
2011 Abraham AK, Maurer TS, Kalgutkar AS, Gao X, Li M, Healy DR, Petersen DN, Griffith DA, Mager DE. Pharmacodynamic model of parathyroid hormone modulation by a negative allosteric modulator of the calcium-sensing receptor. The Aaps Journal. 13: 265-73. PMID 21437757 DOI: 10.1208/S12248-011-9266-9  0.107
2016 Olivier KN, Griffith DE, Eagle G, McGinnis Ii JP, Micioni L, Liu K, Daley CL, Winthrop KL, Ruoss S, Addrizzo-Harris DJ, Flume PA, Dorgan D, Salathe M, Brown-Elliott BA, Gupta R, et al. Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease. American Journal of Respiratory and Critical Care Medicine. PMID 27748623 DOI: 10.1164/rccm.201604-0700OC  0.106
2020 Flume PA, Griffith DE, Chalmers JD, Daley CL, Olivier K, O'Donnell A, Aksamit T, Kasperbauer S, Leitman A, Winthrop KL. Development of Drugs for Nontuberculous Mycobacterial Disease: Clinicians' Interpretation of a US FDA Workshop. Chest. PMID 32853648 DOI: 10.1016/j.chest.2020.08.2055  0.103
2012 Campanella A, Muncrief R, Harold MP, Griffith DC, Whitton NM, Weber RS. Thermolysis of microalgae and duckweed in a CO₂-swept fixed-bed reactor: bio-oil yield and compositional effects. Bioresource Technology. 109: 154-62. PMID 22285294 DOI: 10.1016/j.biortech.2011.12.115  0.102
2018 Waring CL, Hankin SI, Griffith DWT, Kertesz MA, Kobylski V, Wilson NL, Coleman NV, Kettlewell G, Zlot R, Bosse M, Bell G. Author Correction: Seasonal total methane depletion in limestone caves. Scientific Reports. 8: 6059. PMID 29643384 DOI: 10.1038/S41598-018-23872-8  0.102
2018 Milstead RP, Nance KT, Tarnas KS, Egelhofer KE, Griffith DR. Photochemical degradation of halogenated estrogens under natural solar irradiance. Environmental Science. Processes & Impacts. PMID 30211921 DOI: 10.1039/c8em00275d  0.1
2020 Al-Shaer MH, Märtson AG, Alghamdi WA, Alsultan A, An G, Ahmed S, Alkabab Y, Banu S, Houpt ER, Ashkin D, Griffith DE, Cegielski JP, Heysell SK, Peloquin CA. Ethionamide population pharmacokinetic model and target attainment in multidrug-resistant tuberculosis. Antimicrobial Agents and Chemotherapy. PMID 32631828 DOI: 10.1128/AAC.00713-20  0.096
2018 Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, Addrizzo-Harris DJ, O'Donnell AE, Marras TK, Flume PA, Loebinger MR, Morgan L, Codecasa LR, Hill AT, Ruoss SJ, et al. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT): A Prospective, Open-Label, Randomized Study. American Journal of Respiratory and Critical Care Medicine. PMID 30216086 DOI: 10.1164/rccm.201807-1318OC  0.095
2008 Dudley MN, Loutit J, Griffith DC. Aerosol antibiotics: considerations in pharmacological and clinical evaluation. Current Opinion in Biotechnology. 19: 637-43. PMID 19036576 DOI: 10.1016/j.copbio.2008.11.002  0.095
2009 Sabet M, Miller CE, Nolan TG, Senekeo-Effenberger K, Dudley MN, Griffith DC. Efficacy of aerosol MP-376, a levofloxacin inhalation solution, in models of mouse lung infection due to Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 53: 3923-8. PMID 19528273 DOI: 10.1128/AAC.00268-09  0.095
2015 Wenzler E, Gotfried MH, Loutit JS, Durso S, Griffith DC, Dudley MN, Rodvold KA. Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects. Antimicrobial Agents and Chemotherapy. 59: 7232-9. PMID 26349830 DOI: 10.1128/AAC.01713-15  0.094
2017 Weiss WJ, Pulse ME, Nguyen P, Peterson K, Silva J, Simecka JW, Valtierra D, Sabet M, Griffith DC. Activity of Meropenem-Vaborbactam Against Carbapenem-resistant Enterobacteriaceae in a Murine Model of Pyelonephritis. Antimicrobial Agents and Chemotherapy. PMID 29038270 DOI: 10.1128/AAC.01439-17  0.092
2019 Bayliss MAJ, Rigdova K, Kyriakides M, Grier S, Lovering AM, Ellery K, Griffith DC, MacGowan A. Challenges in the bioanalysis of tetracyclines: Epimerisation and chelation with metals. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1134: 121807. PMID 31783250 DOI: 10.1016/j.jchromb.2019.121807  0.092
2020 Sabet M, Tarazi Z, Griffith DC. Pharmacodynamics of Meropenem Against in a Neutropenic Mouse Thigh Infection Model. Antimicrobial Agents and Chemotherapy. PMID 31988101 DOI: 10.1128/AAC.02388-19  0.09
2016 Griffith DE, Aksamit TR. Understanding nontuberculous mycobacterial lung disease: it's been a long time coming. F1000research. 5: 2797. PMID 27990278 DOI: 10.12688/f1000research.9272.1  0.089
2021 Eng H, Bi YA, West MA, Ryu S, Yamaguchi E, Kosa RE, Tess DA, Griffith DA, Litchfield JE, Kalgutkar AS, Varma MVS. . The Journal of Pharmacology and Experimental Therapeutics. PMID 33509903 DOI: 10.1124/jpet.120.000457  0.088
2018 Bear DE, Griffith D, Puthucheary ZA. Emerging outcome measures for nutrition trials in the critically ill. Current Opinion in Clinical Nutrition and Metabolic Care. PMID 30148741 DOI: 10.1097/MCO.0000000000000507  0.087
2018 Griffith DC, Sabet M, Tarazi Z, Lomovskaya O, Dudley MN. Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-lactamase Inhibitor, in Combination with Meropenem. Antimicrobial Agents and Chemotherapy. PMID 30397063 DOI: 10.1128/AAC.01659-18  0.087
2014 Griffith DR, Kido Soule MC, Matsufuji H, Eglinton TI, Kujawinski EB, Gschwend PM. Measuring free, conjugated, and halogenated estrogens in secondary treated wastewater effluent. Environmental Science & Technology. 48: 2569-78. PMID 24476066 DOI: 10.1021/Es402809U  0.087
2019 Sabet M, Griffith DC. Activity of Aerosolized Levofloxacin Against in a Mouse Chronic Lung Infection Model. Antimicrobial Agents and Chemotherapy. PMID 31712215 DOI: 10.1128/AAC.01988-19  0.087
2010 King P, Citron DM, Griffith DC, Lomovskaya O, Dudley MN. Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients. Diagnostic Microbiology and Infectious Disease. 66: 181-6. PMID 19828274 DOI: 10.1016/j.diagmicrobio.2009.09.009  0.086
2017 Sabet M, Tarazi Z, Nolan T, Parkinson J, Rubio-Aparicio D, Lomovskaya O, Dudley MN, Griffith DC. Activity of Meropenem-Vaborbactam in Mouse Models of Infection due to KPC-producing Carbapenem-Resistant Enterobacteriaceae (CRE). Antimicrobial Agents and Chemotherapy. PMID 29109160 DOI: 10.1128/AAC.01446-17  0.086
2010 King P, Lomovskaya O, Griffith DC, Burns JL, Dudley MN. In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis. Antimicrobial Agents and Chemotherapy. 54: 143-8. PMID 19805554 DOI: 10.1128/AAC.00248-09  0.086
2007 Griffith DC, Kelly-Hope LA, Miller MA. Review of reported cholera outbreaks worldwide, 1995-2005. The American Journal of Tropical Medicine and Hygiene. 75: 973-7. PMID 17123999  0.085
2019 Villamor GB, Kliskey AD, Griffith DL, de Haro-Marti ME, Martinez AM, Alfaro M, Alessa L. Landscape social-metabolism in food-energy-water systems: Agricultural transformation of the Upper Snake River Basin. The Science of the Total Environment. 705: 135817. PMID 31841925 DOI: 10.1016/j.scitotenv.2019.135817  0.085
2016 Henkle E, Aksamit T, Barker A, Daley CL, Griffith D, Leitman P, Leitman A, Malanga E, Marras TK, Olivier KN, Prevots DR, Prieto D, Quittner AL, Skach W, Walsh JW, et al. Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report. Annals of the American Thoracic Society. 13: S379-S384. PMID 27627485 DOI: 10.1513/Annalsats.201605-387Ws  0.084
2008 Griffith DC, Rodriguez D, Corcoran E, Dudley MN. Pharmacodynamics of RWJ-54428 against Staphylococcus aureus, Streptococcus pneumoniae, and Enterococcus faecalis in a neutropenic mouse thigh infection model. Antimicrobial Agents and Chemotherapy. 52: 244-7. PMID 17954697 DOI: 10.1128/AAC.00776-07  0.083
2010 Kalgutkar AS, Griffith DA, Ryder T, Sun H, Miao Z, Bauman JN, Didiuk MT, Frederick KS, Zhao SX, Prakash C, Soglia JR, Bagley SW, Bechle BM, Kelley RM, Dirico K, et al. Discovery tactics to mitigate toxicity risks due to reactive metabolite formation with 2-(2-hydroxyaryl)-5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3h)-one derivatives, potent calcium-sensing receptor antagonists and clinical candidate(s) for the treatment of osteoporosis. Chemical Research in Toxicology. 23: 1115-26. PMID 20507089 DOI: 10.1021/Tx100137N  0.083
2020 Winthrop KL, Flume PA, Thomson R, Mange KC, Yuen DW, Ciesielska M, Morimoto K, Ruoss SJ, Codecasa LR, Yim JJ, Marras TK, van Ingen J, Wallace RJ, Brown-Elliott BA, Coulter C, ... Griffith DE, et al. Amikacin Liposome Inhalation Suspension for MAC Lung Disease: A 12-Month Open-Label Extension Study. Annals of the American Thoracic Society. PMID 33326356 DOI: 10.1513/AnnalsATS.202008-925OC  0.082
2003 Griffith DE, Brown-Elliott BA, Wallace RJ. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 37: 1178-82. PMID 14557961 DOI: 10.1086/378742  0.082
2019 Esler WP, Tesz GJ, Hellerstein MK, Beysen C, Sivamani R, Turner SM, Watkins SM, Amor PA, Carvajal-Gonzalez S, Geoly FJ, Biddle KE, Purkal JJ, Fitch M, Buckeridge C, Silvia AM, ... Griffith DA, et al. Human sebum requires de novo lipogenesis, which is increased in acne vulgaris and suppressed by acetyl-CoA carboxylase inhibition. Science Translational Medicine. 11. PMID 31092695 DOI: 10.1126/Scitranslmed.Aau8465  0.082
2024 Liang F, Yu W, Liu X, Griffith D, Golmie N. Towards Edge-Based Deep Learning in Industrial Internet of Things. Ieee Internet of Things Journal. 7. PMID 38486787 DOI: 10.1109/jiot.2019.2963635  0.081
2020 Griffith DE, Aksamit TR. How I Do It: Managing M. avium complex lung disease with a little help from my friend. Chest. PMID 33080299 DOI: 10.1016/j.chest.2020.10.031  0.081
2018 Henkle E, Aksamit TR, Daley CL, Griffith DE, O'Donnell AE, Quittner AL, Malanga E, Prieto D, Leitman A, Winthrop KL. U.S. patient-centered research priorities and roadmap for bronchiectasis. Chest. PMID 29981718 DOI: 10.1016/J.Chest.2018.06.032  0.08
2006 Griffith DC, Corcoran E, Lofland D, Lee A, Cho D, Lomovskaya O, Dudley MN. Pharmacodynamics of levofloxacin against Pseudomonas aeruginosa with reduced susceptibility due to different efflux pumps: do elevated MICs always predict reduced in vivo efficacy? Antimicrobial Agents and Chemotherapy. 50: 1628-32. PMID 16641428 DOI: 10.1128/AAC.50.5.1628-1632.2006  0.08
2017 Sabet M, Tarazi Z, Rubio-Aparicio D, Nolan TG, Parkinson J, Lomovskaya O, Dudley MN, Griffith DC. Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-resistant Enterobacteriaceae in an In Vitro Hollow Fiber Model. Antimicrobial Agents and Chemotherapy. PMID 29133570 DOI: 10.1128/AAC.01969-17  0.08
2011 Tsivkovskii R, Sabet M, Tarazi Z, Griffith DC, Lomovskaya O, Dudley MN. Levofloxacin reduces inflammatory cytokine levels in human bronchial epithelia cells: implications for aerosol MP-376 (levofloxacin solution for inhalation) treatment of chronic pulmonary infections. Fems Immunology and Medical Microbiology. 61: 141-6. PMID 21073547 DOI: 10.1111/j.1574-695X.2010.00755.x  0.079
2021 Ghaffar S, Blankenstein TN, Patel D, Theodosiou C, Griffith D. Quantification of the effect of body mass index on cricothyroid membrane depth: a cross-sectional analysis of clinical CT images. Emergency Medicine Journal : Emj. PMID 33627374 DOI: 10.1136/emermed-2019-209046  0.079
2002 Brown-Elliott BA, Griffith DE, Wallace RJ. Diagnosis of nontuberculous mycobacterial infections. Clinics in Laboratory Medicine. 22: 911-25, vi. PMID 12489287 DOI: 10.1016/S0272-2712(02)00018-5  0.078
2018 Sabet M, Tarazi Z, Griffith DC. Activity of Meropenem-Vaborbactam Against and in a Neutropenic Mouse Thigh Infection Model. Antimicrobial Agents and Chemotherapy. PMID 30323049 DOI: 10.1128/AAC.01665-18  0.077
2018 Sime FB, Pandey S, Karamujic N, Parker S, Alexander E, Loutit J, Durso S, Griffith D, Lipman J, Wallis SC, Roberts JA. characterisation of effects of renal replacement therapy modalities and settings on pharmacokinetics of meropenem and vaborbactam. Antimicrobial Agents and Chemotherapy. PMID 30082292 DOI: 10.1128/AAC.01306-18  0.077
2003 Glinka T, Huie K, Cho A, Ludwikow M, Blais J, Griffith D, Hecker S, Dudley M. Relationships between structure, antibacterial activity, serum stability, pharmacokinetics and efficacy in 3-(heteroarylthio)cephems. Discovery of RWJ-333441 (MC-04,546). Bioorganic & Medicinal Chemistry. 11: 591-600. PMID 12538024  0.077
2020 Jones JRA, Griffith DM. The 6 Ps of post-ICU recovery: application of a shared conceptual model. Current Opinion in Clinical Nutrition and Metabolic Care. PMID 32740161 DOI: 10.1097/MCO.0000000000000682  0.076
2017 Henkle E, Aksamit TR, Barker AF, Curtis JR, Daley CL, Daniels ML, DiMango A, Eden E, Fennelly K, Griffith DE, Johnson M, Knowles MR, Leitman A, Leitman P, Malanga E, et al. Pharmacotherapy for non-cystic fibrosis bronchiectasis: results from an NTM Info & Research patient survey and the Bronchiectasis and NTM Research Registry. Chest. PMID 28479113 DOI: 10.1016/j.chest.2017.04.167  0.076
2024 Liang F, Yu W, Liu X, Griffith D, Golmie N. Towards Deep Q-Network Based Resource Allocation in Industrial Internet of Things. Ieee Internet of Things Journal. 9. PMID 38486943 DOI: 10.1109/JIOT.2021.3093346  0.075
2016 Brown-Elliott BA, Philley JV, Griffith DE, Thakkar F, Wallace RJ. In Vitro Susceptibility Testing of Bedaquiline Against Mycobacterium avium Complex. Antimicrobial Agents and Chemotherapy. PMID 27872065 DOI: 10.1128/AAC.01798-16  0.075
2022 Lange C, Böttger EC, Cambau E, Griffith DE, Guglielmetti L, van Ingen J, Knight SL, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, Wagner D, Winthrop K, Daley CL. Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. The Lancet. Infectious Diseases. PMID 35090639 DOI: 10.1016/S1473-3099(21)00586-7  0.074
2015 Griffith DE, Brown-Elliott BA, Benwill JL, Wallace RJ. Mycobacterium abscessus. "Pleased to meet you, hope you guess my name...". Annals of the American Thoracic Society. 12: 436-9. PMID 25643064 DOI: 10.1513/AnnalsATS.201501-015OI  0.073
2018 Merriweather JL, Griffith DM, Walsh TS. Appetite during the recovery phase of critical illness: a cohort study. European Journal of Clinical Nutrition. PMID 29773846 DOI: 10.1038/s41430-018-0181-3  0.073
2024 Taylor R, Zhang C, George D, Kotecha S, Abdelghaffar M, Forster T, Santos Rodrigues PD, Reisinger AC, White D, Hamilton F, Watkins WJ, Griffith DM, Ghazal P. Low circulatory levels of total cholesterol, HDL-C and LDL-C are associated with death of patients with sepsis and critical illness: systematic review, meta-analysis, and perspective of observational studies. Ebiomedicine. 100: 104981. PMID 38290288 DOI: 10.1016/j.ebiom.2024.104981  0.073
2021 Griffith DE, Daley CL. Treatment of Mycobacterium abscessus Pulmonary Disease. Chest. PMID 34314673 DOI: 10.1016/j.chest.2021.07.035  0.073
2020 Tess DA, Eng H, Kalgutkar AS, Litchfield J, Edmonds DJ, Griffith DA, Varma MVS. Predicting the Human Hepatic Clearance of Acidic and Zwitterionic Drugs. Journal of Medicinal Chemistry. PMID 32985885 DOI: 10.1021/acs.jmedchem.0c01033  0.073
2021 Pauley E, Drake TM, Griffith DM, Sigfrid L, Lone NI, Harrison EM, Baillie JK, Scott JT, Walsh TS, Semple MG, Docherty AB. Recovery from Covid-19 critical illness: A secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial. Journal of the Intensive Care Society. 24: 162-169. PMID 37255989 DOI: 10.1177/17511437211052226  0.073
2015 Griffith DE, Adjemian J, Brown-Elliott BA, Prevots DR, Philley JV, Olivier KN, Wallace RJ. Reply: Cure Not Possible, by Definition. American Journal of Respiratory and Critical Care Medicine. 192: 1256-7. PMID 26568244 DOI: 10.1164/rccm.201508-1515LE  0.073
2020 Basavaraj A, Choate R, Addrizzo-Harris D, Aksamit TR, Barker A, Daley CL, Anne Daniels ML, Eden E, DiMango A, Fennelly K, Griffith DE, Johnson MM, Knowles MR, Metersky ML, Noone PG, et al. Airway clearance techniques in bronchiectasis: Analysis from the United States Bronchiectasis and NTM Research Registry. Chest. PMID 32622820 DOI: 10.1016/j.chest.2020.06.050  0.073
2014 Griffith DA, Kung DW, Esler WP, Amor PA, Bagley SW, Beysen C, Carvajal-Gonzalez S, Doran SD, Limberakis C, Mathiowetz AM, McPherson K, Price DA, Ravussin E, Sonnenberg GE, Southers JA, et al. Decreasing the rate of metabolic ketone reduction in the discovery of a clinical acetyl-CoA carboxylase inhibitor for the treatment of diabetes. Journal of Medicinal Chemistry. 57: 10512-26. PMID 25423286 DOI: 10.1021/Jm5016022  0.072
2021 Saxena AR, Gorman DN, Esquejo RM, Bergman A, Chidsey K, Buckeridge C, Griffith DA, Kim AM. Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial. Nature Medicine. PMID 34127852 DOI: 10.1038/s41591-021-01391-w  0.071
2017 Philley JV, Kannan A, Griffith DE, Devine MS, Benwill JL, Jr RJ, Brown-Elliott BA, Thakkar F, Taskar V, Fox JG, Alqaid A, Bains H, Gupta S, Dasgupta S. Exosome secretome and mediated signaling in breast cancer patients with nontuberculous mycobacterial disease. Oncotarget. PMID 28160560 DOI: 10.18632/oncotarget.14964  0.071
2014 Griffith DE. Mycobacterium abscessus subsp abscessus lung disease: 'trouble ahead, trouble behind…'. F1000prime Reports. 6: 107. PMID 25580261 DOI: 10.12703/P6-107  0.071
2021 Reyes L, A Sanchez-Garcia M, Morrison T, Howden AJM, Watts ER, Arienti S, Sadiku P, Coelho P, Mirchandani AS, Zhang A, Hope D, Clark SK, Singleton J, Johnston S, Grecian R, ... ... Griffith D, et al. -------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--. Wellcome Open Research. 6: 38. PMID 33997298 DOI: 10.12688/wellcomeopenres.16584.1  0.07
2018 Rubino CM, Bhavnani SM, Loutit JS, Morgan EE, White D, Dudley MN, Griffith DC. Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics Vaborbactam and Meropenem Alone and in Combination Following Single and Multiple Doses in Healthy Adult Subjects. Antimicrobial Agents and Chemotherapy. PMID 29437614 DOI: 10.1128/AAC.02228-17  0.07
2002 Griffith DE. Management of disease due to Mycobacterium kansasii. Clinics in Chest Medicine. 23: 613-21, vi. PMID 12370997 DOI: 10.1016/S0272-5231(02)00016-3  0.07
2002 Brown-Elliott BA, Griffith DE, Wallace RJ. Newly described or emerging human species of nontuberculous mycobacteria. Infectious Disease Clinics of North America. 16: 187-220. PMID 11917813 DOI: 10.1016/S0891-5520(03)00052-7  0.069
2023 Jones JRA, Karahalios A, Puthucheary ZA, Berry MJ, Files DC, Griffith DM, McDonald LA, Morris PE, Moss M, Nordon-Craft A, Walsh T, Berney S, Denehy L. Responsiveness of Critically Ill Adults With Multimorbidity to Rehabilitation Interventions: A Patient-Level Meta-Analysis Using Individual Pooled Data From Four Randomized Trials. Critical Care Medicine. PMID 37246922 DOI: 10.1097/CCM.0000000000005936  0.069
2021 Seaborn T, Griffith D, Kliskey A, Caudill CC. Building a Bridge Between Adaptive Capacity and Adaptive Potential to Understand Responses to Environmental Change. Global Change Biology. PMID 33666302 DOI: 10.1111/gcb.15579  0.069
2018 Tarazi Z, Sabet M, Dudley MN, Griffith DC. Pharmacodynamics of Minocycline Against in a Rat Pneumonia Model. Antimicrobial Agents and Chemotherapy. PMID 30397059 DOI: 10.1128/AAC.01671-18  0.069
2010 Hadcock JR, Carpino PA, Iredale PA, Dow RL, Gautreau D, Thiede L, Kelly-Sullivan D, Lizano JS, Liu X, Van Deusen J, Ward KM, O'Connor RE, Black SC, Griffith DA, Scott DO. Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) receptor antagonist. Bmc Pharmacology. 10: 9. PMID 20712891 DOI: 10.1186/1471-2210-10-9  0.068
2020 Huard K, Smith AC, Cappon GD, Dow RL, Edmonds DJ, El-Kattan A, Esler WP, Fernando DP, Griffith DA, Kalgutkar AS, Ross T, Bagley SW, Beebe D, Bi YA, Cabral S, et al. Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase (ACC) Inhibitors Through Liver Targeting. Journal of Medicinal Chemistry. PMID 32809824 DOI: 10.1021/Acs.Jmedchem.0C00640  0.068
2023 Siegel SAR, Griffith DE, Philley JV, Brown-Elliott BA, Brunton AE, Sullivan PE, Fuss C, Strnad L, Wallace RJ, Winthrop KL. Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease. Chest. PMID 37419144 DOI: 10.1016/j.chest.2023.05.036  0.068
2015 Philley JV, Wallace RJ, Benwill JL, Taskar V, Brown-Elliott BA, Thakkar F, Aksamit TR, Griffith DE. Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease. Chest. 148: 499-506. PMID 25675393 DOI: 10.1378/chest.14-2764  0.068
2021 Rubino CM, Onufrak NJ, van Ingen J, Griffith DE, Bhavnani SM, Yuen DW, Mange KC, Winthrop KL. Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease. European Journal of Drug Metabolism and Pharmacokinetics. PMID 33595792 DOI: 10.1007/s13318-020-00669-7  0.068
2022 Raja Reddy K, Totrov M, Lomovskaya O, Griffith DC, Tarazi Z, Clifton MC, Hecker SJ. Broad-spectrum cyclic boronate β-lactamase inhibitors featuring an intramolecular prodrug for oral bioavailability. Bioorganic & Medicinal Chemistry. 62: 116722. PMID 35358864 DOI: 10.1016/j.bmc.2022.116722  0.068
2020 Hecker SJ, Reddy KR, Lomovskaya O, Griffith DC, Rubio-Aparicio D, Nelson K, Tsivkovski R, Sun D, Sabet M, Tarazi Z, Parkinson J, Totrov M, Boyer SH, Glinka TW, Pemberton OA, et al. Discovery of Cyclic Boronic Acid QPX7728, an Ultra-broad-spectrum Inhibitor of Serine and Metallo Beta-lactamases. Journal of Medicinal Chemistry. PMID 32150407 DOI: 10.1021/acs.jmedchem.9b01976  0.067
2002 Wallace Jr RJ, Zhang Y, Brown-Elliott BA, Yakrus MA, Wilson RW, Mann L, Couch L, Girard WM, Griffith DE. Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis. The Journal of Infectious Diseases. 186: 266-73. PMID 12134265 DOI: 10.1086/341207  0.066
2020 Jones JRA, Berney S, Berry MJ, Files DC, Griffith DM, McDonald LA, Morris PE, Moss M, Nordon-Craft A, Walsh T, Gordon I, Karahalios A, Puthucheary Z, Denehy L. Response to physical rehabilitation and recovery trajectories following critical illness: individual participant data meta-analysis protocol. Bmj Open. 10: e035613. PMID 32371516 DOI: 10.1136/bmjopen-2019-035613  0.066
2014 Adjemian J, Prevots DR, Gallagher J, Heap K, Gupta R, Griffith D. Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease. Annals of the American Thoracic Society. 11: 9-16. PMID 24236749 DOI: 10.1513/AnnalsATS.201304-085OC  0.066
2016 Alexander DC, Vasireddy R, Vasireddy S, Philley JV, Brown-Elliott BA, Perry B, Griffith DE, Benwill JL, Cameron AD, Wallace RJ. The Emergence of mmpT5 Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung Disease. Journal of Clinical Microbiology. PMID 27927925 DOI: 10.1128/JCM.02087-16  0.066
2006 Griffith DA. Human Capital in the Supply Chain of Global Firms. Organizational Dynamics. 35: 251-263. PMID 32287487 DOI: 10.1016/J.Orgdyn.2006.05.004  0.066
2020 Choate R, Aksamit TR, Mannino D, Addrizzo-Harris D, Barker A, Basavaraj A, Daley CL, Daniels MLA, Eden E, DiMango A, Fennelly K, Griffith DE, Johnson MM, Knowles MR, McShane PJ, et al. Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study. Respiratory Medicine. 177: 106285. PMID 33401148 DOI: 10.1016/j.rmed.2020.106285  0.065
2013 Philley JV, Griffith DE. Management of nontuberculous mycobacterial (NTM) lung disease. Seminars in Respiratory and Critical Care Medicine. 34: 135-42. PMID 23460013 DOI: 10.1055/s-0033-1333575  0.064
2013 Eng H, Sharma R, McDonald TS, Edmonds DJ, Fortin JP, Li X, Stevens BD, Griffith DA, Limberakis C, Nolte WM, Price DA, Jackson M, Kalgutkar AS. Demonstration of the innate electrophilicity of 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a small-molecule positive allosteric modulator of the glucagon-like peptide-1 receptor. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 1470-9. PMID 23653442 DOI: 10.1124/Dmd.113.052183  0.064
2016 Tortoli E, Kohl TA, Brown-Elliott BA, Trovato A, Cardoso Leao S, Garcia MJ, Vasireddy S, Turenne CY, Griffith DE, Philley JV, Baldan R, Campana S, Cariani L, Colombo C, Taccetti G, et al. Emended description of Mycobacterium abscessus, Mycobacterium abscessus subs. abscessus, Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov. International Journal of Systematic and Evolutionary Microbiology. PMID 27499141 DOI: 10.1099/ijsem.0.001376  0.064
2018 Wunderink RG, Giamarellos-Bourboulis EJ, Rahav G, Mathers AJ, Bassetti M, Vazquez J, Cornely OA, Solomkin J, Bhowmick T, Bishara J, Daikos GL, Felton T, Furst MJL, Kwak EJ, Menichetti F, ... ... Griffith D, et al. Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial. Infectious Diseases and Therapy. PMID 30270406 DOI: 10.1007/s40121-018-0214-1  0.064
2019 Henkle E, Curtis JR, Chen L, Chan B, Aksamit TR, Daley CL, Griffith DE, Winthrop KL. Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis. The European Respiratory Journal. PMID 31000676 DOI: 10.1183/13993003.01896-2018  0.064
2020 Schildkraut JA, Gallagher J, Morimoto K, Lange C, Haworth C, Floto RA, Hoefsloot W, Griffith DE, Wagner D, Ingen JV. Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation. Respiratory Medicine. 173: 106164. PMID 32992265 DOI: 10.1016/j.rmed.2020.106164  0.064
2016 Griffith DC, Loutit JS, Morgan EE, Durso S, Dudley MN. A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of the Beta-lactamase inhibitor Vaborbactam (RPX7009) in Healthy Adult Subjects. Antimicrobial Agents and Chemotherapy. PMID 27527080 DOI: 10.1128/AAC.00568-16  0.063
2018 Rubino CM, Bhavnani SM, Loutit JS, Lohse B, Dudley MN, Griffith DC. Meropenem-Vaborbactam: Single-Dose Pharmacokinetics and Safety in Subjects with Chronic Renal Impairment. Antimicrobial Agents and Chemotherapy. PMID 29311069 DOI: 10.1128/AAC.02103-17  0.063
2015 Swedberg JE, Schroeder CI, Mitchell JM, Durek T, Fairlie DP, Edmonds DJ, Griffith DA, Ruggeri RB, Derksen DR, Loria PM, Liras S, Price DA, Craik DJ. Cyclic alpha-conotoxin peptidomimetic chimeras as potent GLP-1R agonists. European Journal of Medicinal Chemistry. 103: 175-184. PMID 26352676 DOI: 10.1016/J.Ejmech.2015.08.046  0.063
2003 Griffith DC, Harford L, Williams R, Lee VJ, Dudley MN. In vivo antibacterial activity of RWJ-54428, a new cephalosporin with activity against gram-positive bacteria. Antimicrobial Agents and Chemotherapy. 47: 43-7. PMID 12499167 DOI: 10.1128/AAC.47.1.43-47.2003  0.063
2013 Brown-Elliott BA, Iakhiaeva E, Griffith DE, Woods GL, Stout JE, Wolfe CR, Turenne CY, Wallace RJ. In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates. Journal of Clinical Microbiology. 51: 3389-94. PMID 23946523 DOI: 10.1128/JCM.01612-13  0.062
2005 Griffith DE, Brown-Elliott BA, Shepherd S, McLarty J, Griffith L, Wallace RJ. Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease. American Journal of Respiratory and Critical Care Medicine. 172: 250-3. PMID 15860751 DOI: 10.1164/rccm.200407-863OC  0.062
2003 Diggory P, Cauchi L, Griffith D, Jones V, Lawrence E, Mehta A, O'Mahony P, Vigus J. The influence of new guidelines on cardiopulmonary resuscitation (CPR) decisions. Five cycles of audit of a clerk proforma which included a resuscitation decision. Resuscitation. 56: 159-65. PMID 12589989  0.062
2012 Huard K, Bagley SW, Menhaji-Klotz E, Préville C, Southers JA, Smith AC, Edmonds DJ, Lucas JC, Dunn MF, Allanson NM, Blaney EL, Garcia-Irizarry CN, Kohrt JT, Griffith DA, Dow RL. Synthesis of spiropiperidine lactam acetyl-CoA carboxylase inhibitors. The Journal of Organic Chemistry. 77: 10050-7. PMID 23127254 DOI: 10.1021/jo3014808  0.062
2021 Lomovskaya O, Tsivkovski R, Sun D, Reddy R, Totrov M, Hecker S, Griffith D, Loutit J, Dudley M. QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics. Frontiers in Microbiology. 12: 697180. PMID 34290688 DOI: 10.3389/fmicb.2021.697180  0.061
2018 Fregonese F, Ahuja SD, Akkerman OW, Arakaki-Sanchez D, Ayakaka I, Baghaei P, Bang D, Bastos M, Benedetti A, Bonnet M, Cattamanchi A, Cegielski P, Chien JY, Cox H, Dedicoat M, ... ... Griffith D, et al. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis. The Lancet. Respiratory Medicine. 6: 265-275. PMID 29595509 DOI: 10.1016/S2213-2600(18)30078-X  0.061
2016 Griffith DM, Vale ME, Campbell C, Lewis S, Walsh TS. Persistent inflammation and recovery after intensive care: A systematic review. Journal of Critical Care. PMID 26880401 DOI: 10.1016/j.jcrc.2016.01.011  0.061
2014 Maeng DD, Starr AE, Tomcavage JF, Sciandra J, Salek D, Griffith D. Can telemonitoring reduce hospitalization and cost of care? A health plan's experience in managing patients with heart failure. Population Health Management. 17: 340-4. PMID 24865986 DOI: 10.1089/pop.2013.0107  0.061
2019 Gadsby NJ, McHugh MP, Forbes C, MacKenzie L, Hamilton SKD, Griffith DM, Templeton KE. Comparison of Unyvero P55 Pneumonia Cartridge, in-house PCR and culture for the identification of respiratory pathogens and antibiotic resistance in bronchoalveolar lavage fluids in the critical care setting. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. PMID 30859358 DOI: 10.1007/s10096-019-03526-x  0.06
2012 Griffith DE, Aksamit TR. Bronchiectasis and nontuberculous mycobacterial disease. Clinics in Chest Medicine. 33: 283-95. PMID 22640846 DOI: 10.1016/j.ccm.2012.02.002  0.06
2013 Walker CA, Griffith DM, Gray AJ, Datta D, Hay AW. Early lactate clearance in septic patients with elevated lactate levels admitted from the emergency department to intensive care: time to aim higher? Journal of Critical Care. 28: 832-7. PMID 23602032 DOI: 10.1016/j.jcrc.2013.02.004  0.06
2022 Roberts KD, Zhu Y, Azad MAK, Han ML, Wang J, Wang L, Yu HH, Horne AS, Pinson JA, Rudd D, Voelcker NH, Patil NA, Zhao J, Jiang X, Lu J, ... ... Griffith DC, et al. A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens. Nature Communications. 13: 1625. PMID 35338128 DOI: 10.1038/s41467-022-29234-3  0.06
2021 Griffith DE, Winthrop KL. You Gotta Make Me See, What Does It Mean to Have an MIC? Chest. 159: 462-464. PMID 33563427 DOI: 10.1016/j.chest.2020.11.007  0.06
2004 Diggory P, Shire L, Griffith D, Jones V, Lawrence E, Mehta A, O'Mahony P, Vigus J. Influence of guidelines on CPR decisions: an audit of clerking proforma. Clinical Medicine (London, England). 4: 424-6. PMID 15536870  0.06
2009 Dow RL, Carpino PA, Hadcock JR, Black SC, Iredale PA, DaSilva-Jardine P, Schneider SR, Paight ES, Griffith DA, Scott DO, O'Connor RE, Nduaka CI. Discovery of 2-(2-chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2H-pyrazolo[3,4-f][1,4]oxazepin-8(5H)-one (PF-514273), a novel, bicyclic lactam-based cannabinoid-1 receptor antagonist for the treatment of obesity. Journal of Medicinal Chemistry. 52: 2652-5. PMID 19351113 DOI: 10.1021/jm900255t  0.06
2014 Wallace RJ, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, York DS, Shepherd S, Griffith DE. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease. Chest. 146: 276-82. PMID 24457542 DOI: 10.1378/chest.13-2538  0.059
2011 Geller DE, Flume PA, Griffith DC, Morgan E, White D, Loutit JS, Dudley MN. Pharmacokinetics and safety of MP-376 (levofloxacin inhalation solution) in cystic fibrosis subjects. Antimicrobial Agents and Chemotherapy. 55: 2636-40. PMID 21444699 DOI: 10.1128/AAC.01744-10  0.059
2015 Philley JV, Griffith DE. Treatment of slowly growing mycobacteria. Clinics in Chest Medicine. 36: 79-90. PMID 25676521 DOI: 10.1016/j.ccm.2014.10.005  0.059
2021 Griffith DE, Thomson R, Flume PA, Aksamit TR, Field SK, Addrizzo-Harris DJ, Morimoto K, Hoefsloot W, Mange KC, Yuen DW, Ciesielska M, Wallace RJ, van Ingen J, Brown-Elliott BA, Coulter C, et al. Amikacin Liposome Inhalation Suspension for Refractory MAC Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-Term Exposure. Chest. PMID 33887244 DOI: 10.1016/j.chest.2021.03.070  0.059
2011 Griffith DA, Hargrove DM, Maurer TS, Blum CA, De Lombaert S, Inthavongsay JK, Klade LE, Mack CM, Rose CR, Sanders MJ, Carpino PA. Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21: 2641-5. PMID 21295475 DOI: 10.1016/j.bmcl.2010.12.116  0.059
2014 Nielsen DS, Hoang HN, Lohman RJ, Hill TA, Lucke AJ, Craik DJ, Edmonds DJ, Griffith DA, Rotter CJ, Ruggeri RB, Price DA, Liras S, Fairlie DP. Improving on nature: making a cyclic heptapeptide orally bioavailable. Angewandte Chemie (International Ed. in English). 53: 12059-63. PMID 25219505 DOI: 10.1002/Anie.201405364  0.059
2017 Seaworth BJ, Griffith DE. Therapy of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis. Microbiology Spectrum. 5. PMID 28361737 DOI: 10.1128/microbiolspec.TNMI7-0042-2017  0.058
2019 Philley JV, Griffith DE. Medical Management of Pulmonary Nontuberculous Mycobacterial Disease. Thoracic Surgery Clinics. 29: 65-76. PMID 30454923 DOI: 10.1016/j.thorsurg.2018.09.001  0.058
2019 Cowman S, van Ingen J, Griffith D, Loebinger MR. Non-tuberculous mycobacterial pulmonary disease. The European Respiratory Journal. PMID 31221809 DOI: 10.1183/13993003.00250-2019  0.058
2015 Griffith DE, Adjemian J, Brown-Elliott BA, Philley JV, Prevots DR, Gaston C, Olivier KN, Wallace RJ. Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease. American Journal of Respiratory and Critical Care Medicine. 192: 754-60. PMID 26068042 DOI: 10.1164/rccm.201503-0444OC  0.058
2023 Peters J, Maselli DJ, Mangat M, Coalson JJ, Hinojosa C, Giavedoni L, Brown-Elliott BA, Chan E, Griffith D. A marmoset model for Mycobacterium avium complex pulmonary disease. Plos One. 18: e0260563. PMID 36893126 DOI: 10.1371/journal.pone.0260563  0.057
2012 Walsh TS, Salisbury LG, Boyd J, Ramsay P, Merriweather J, Huby G, Forbes J, Rattray JZ, Griffith DM, Mackenzie SJ, Hull A, Lewis S, Murray GD. A randomised controlled trial evaluating a rehabilitation complex intervention for patients following intensive care discharge: the RECOVER study. Bmj Open. 2. PMID 22761291 DOI: 10.1136/bmjopen-2012-001475  0.057
2012 Griffith DE, Aksamit TR. Therapy of refractory nontuberculous mycobacterial lung disease. Current Opinion in Infectious Diseases. 25: 218-27. PMID 22327466 DOI: 10.1097/QCO.0b013e3283511a64  0.057
2015 Wu TS, Yang CH, Brown-Elliott BA, Chao AS, Leu HS, Wu TL, Lin CS, Griffith DE, Chiu CH. Postcesarean section wound infection caused by Mycobacterium massiliense. Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. PMID 26350122 DOI: 10.1016/j.jmii.2015.06.010  0.056
2015 Hecker SJ, Reddy KR, Totrov M, Hirst GC, Lomovskaya O, Griffith DC, King P, Tsivkovski R, Sun D, Sabet M, Tarazi Z, Clifton MC, Atkins K, Raymond A, Potts KT, et al. Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases. Journal of Medicinal Chemistry. 58: 3682-92. PMID 25782055 DOI: 10.1021/Acs.Jmedchem.5B00127  0.056
2014 Wallace RJ, Dukart G, Brown-Elliott BA, Griffith DE, Scerpella EG, Marshall B. Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections. The Journal of Antimicrobial Chemotherapy. 69: 1945-53. PMID 24633206 DOI: 10.1093/jac/dku062  0.056
2016 Newcombe G, Campbell J, Griffith D, Baynes M, Launchbaugh K, Pendleton R. Revisiting the Life Cycle of Dung Fungi, Including Sordaria fimicola. Plos One. 11: e0147425. PMID 26839959 DOI: 10.1371/Journal.Pone.0147425  0.056
2016 Shepherd SJ, Newman R, Brett SJ, Griffith DM. Pharmacological Therapy for the Prevention and Treatment of Weakness After Critical Illness: A Systematic Review. Critical Care Medicine. PMID 26958749 DOI: 10.1097/CCM.0000000000001652  0.056
2002 Daley CL, Griffith DE. Pulmonary disease caused by rapidly growing mycobacteria. Clinics in Chest Medicine. 23: 623-32, vii. PMID 12370998 DOI: 10.1016/S0272-5231(02)00021-7  0.056
2020 Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32628747 DOI: 10.1093/cid/ciaa241  0.056
2023 Griffith DE, Aksamit TR. Diagnostic Criteria and the Decision to Treat Nontuberculous Mycobacterial Pulmonary Disease. Clinics in Chest Medicine. 44: 757-769. PMID 37890914 DOI: 10.1016/j.ccm.2023.07.003  0.056
2015 Walsh TS, Salisbury LG, Merriweather JL, Boyd JA, Griffith DM, Huby G, Kean S, Mackenzie SJ, Krishan A, Lewis SC, Murray GD, Forbes JF, Smith J, Rattray JE, Hull AM, et al. Increased Hospital-Based Physical Rehabilitation and Information Provision After Intensive Care Unit Discharge: The RECOVER Randomized Clinical Trial. Jama Internal Medicine. 175: 901-10. PMID 25867659 DOI: 10.1001/jamainternmed.2015.0822  0.055
2020 Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 71: 905-913. PMID 32797222 DOI: 10.1093/cid/ciaa1125  0.055
2014 Aksamit TR, Philley JV, Griffith DE. Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials. Respiratory Medicine. 108: 417-25. PMID 24484653 DOI: 10.1016/j.rmed.2013.09.014  0.055
2020 Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. The European Respiratory Journal. 56. PMID 32636299 DOI: 10.1183/13993003.00535-2020  0.055
2015 Wallner M, Kolesnik E, Ablasser K, Khafaga M, Wakula P, Ljubojevic S, Thon-Gutschi EM, Sourij H, Kapl M, Edmunds NJ, Kuzmiski JB, Griffith DA, Knez I, Pieske B, von Lewinski D. Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium. Journal of Molecular and Cellular Cardiology. PMID 26432951 DOI: 10.1016/J.Yjmcc.2015.09.018  0.054
2006 Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, Catanzaro A. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. American Journal of Respiratory and Critical Care Medicine. 173: 1283-9. PMID 16514112 DOI: 10.1164/rccm.200509-1531OC  0.054
2022 Xu H, Yu W, Griffith D, Golmie N. A Survey on Industrial Internet of Things: A Cyber-Physical Systems Perspective. Ieee Access : Practical Innovations, Open Solutions. 6. PMID 35531371 DOI: 10.1109/access.2018.2884906  0.054
2016 Griffith DM, Lewis S, Rossi AG, Rennie J, Salisbury L, Merriweather JL, Templeton K, Walsh TS. Systemic inflammation after critical illness: relationship with physical recovery and exploration of potential mechanisms. Thorax. PMID 27118812 DOI: 10.1136/thoraxjnl-2015-208114  0.053
2002 Griffith DE, Brown-Elliott BA, Wallace RJ. Diagnosing nontuberculous mycobacterial lung disease. A process in evolution. Infectious Disease Clinics of North America. 16: 235-49. PMID 11917815 DOI: 10.1016/S0891-5520(03)00054-0  0.053
2013 Griffith DA, Dow RL, Huard K, Edmonds DJ, Bagley SW, Polivkova J, Zeng D, Garcia-Irizarry CN, Southers JA, Esler W, Amor P, Loomis K, McPherson K, Bahnck KB, Préville C, et al. Spirolactam-based acetyl-CoA carboxylase inhibitors: toward improved metabolic stability of a chromanone lead structure. Journal of Medicinal Chemistry. 56: 7110-9. PMID 23981033 DOI: 10.1021/jm401033t  0.053
2016 Ramsay P, Huby G, Merriweather J, Salisbury L, Rattray J, Griffith D, Walsh T. Patient and carer experience of hospital-based rehabilitation from intensive care to hospital discharge: mixed methods process evaluation of the RECOVER randomised clinical trial. Bmj Open. 6: e012041. PMID 27481624 DOI: 10.1136/bmjopen-2016-012041  0.053
2023 Aspnes GE, Bagley SW, Coffey SB, Conn EL, Curto JM, Edmonds DJ, Genovino J, Griffith DA, Ingle G, Jiao W, Limberakis C, Mathiowetz AM, Piotrowski DW, Rose CR, Ruggeri RB, et al. 6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptor. Bioorganic & Medicinal Chemistry Letters. 94: 129454. PMID 37591316 DOI: 10.1016/j.bmcl.2023.129454  0.052
2012 Bagley SW, Southers JA, Cabral S, Rose CR, Bernhardson DJ, Edmonds DJ, Polivkova J, Yang X, Kung DW, Griffith DA, Bader SJ. Synthesis of 7-oxo-dihydrospiro[indazole-5,4'-piperidine] acetyl-CoA carboxylase inhibitors. The Journal of Organic Chemistry. 77: 1497-506. PMID 22239115 DOI: 10.1021/Jo202377G  0.052
2015 Griffith DE, Philley JV, Brown-Elliott BA, Benwill JL, Shepherd S, York D, Wallace RJ. The significance of Mycobacterium abscessus subspecies abscessus isolation during Mycobacterium avium complex lung disease therapy. Chest. 147: 1369-75. PMID 25357074 DOI: 10.1378/chest.14-1297  0.052
2010 Hadcock JR, Griffith DA, Iredale PA, Carpino PA, Dow RL, Black SC, O'Connor R, Gautreau D, Lizano JS, Ward K, Hargrove DM, Kelly-Sullivan D, Scott DO. In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB(1) receptor antagonist for the management of obesity. Biochemical and Biophysical Research Communications. 394: 366-71. PMID 20211605 DOI: 10.1016/j.bbrc.2010.03.015  0.052
2016 Loutit J, Fusaro K, Zhang S, Morgan E, Alexander E, Griffith D, Lomovskaya O, Dudley MN. Meropenem-Vaborbactam (M-V) Compared With Piperacillin-Tazobactam (P-T) in the Treatment of Adults With Complicated Urinary Tract Infections (cUTI), Including Acute Pyelonephritis (AP) in a Phase 3 Randomized, Double-Blind, Double-Dummy Trial (TANGO 1) Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw195.07  0.052
2003 Watkins WJ, Landaverry Y, Léger R, Litman R, Renau TE, Williams N, Yen R, Zhang JZ, Chamberland S, Madsen D, Griffith D, Tembe V, Huie K, Dudley MN. The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitors. Bioorganic & Medicinal Chemistry Letters. 13: 4241-4. PMID 14623009 DOI: 10.1016/j.bmcl.2003.07.030  0.052
2012 Bhattacharya SK, Aspnes GE, Bagley SW, Boehm M, Brosius AD, Buckbinder L, Chang JS, Dibrino J, Eng H, Frederick KS, Griffith DA, Griffor MC, Guimarães CR, Guzman-Perez A, Han S, et al. Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 22: 7523-9. PMID 23153798 DOI: 10.1016/J.Bmcl.2012.10.039  0.052
2006 Griffith DE, Brown-Elliott BA, Langsjoen B, Zhang Y, Pan X, Girard W, Nelson K, Caccitolo J, Alvarez J, Shepherd S, Wilson R, Graviss EA, Wallace RJ. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. American Journal of Respiratory and Critical Care Medicine. 174: 928-34. PMID 16858014 DOI: 10.1164/rccm.200603-450OC  0.051
2018 Griffith DM, Salisbury LG, Lee RJ, Lone N, Merriweather JL, Walsh TS. Determinants of Health-Related Quality of Life After ICU: Importance of Patient Demographics, Previous Comorbidity, and Severity of Illness. Critical Care Medicine. PMID 29293149 DOI: 10.1097/CCM.0000000000002952  0.051
2013 Seaworth BJ, Armitige LY, Griffith DE. First do no harm--adverse events, drug intolerance, and hepatotoxicity: how can we not justify directly observed therapy for treating tuberculosis? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 1063-4. PMID 23811418 DOI: 10.1093/cid/cit432  0.051
2021 Seaton RA, Cooper L, Gibbons CL, Malcolm W, Choo-Kang B, Griffith D, Dundas S, Brittain S, Hamilton K, Jeffreys D, McKinney R, Guthrie D, Sneddon J. Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals. Jac-Antimicrobial Resistance. 3: dlab078. PMID 34223137 DOI: 10.1093/jacamr/dlab078  0.051
2021 Griffith DC, Morgan EE, Dudley MN, Loutit JS. A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Biapenem in Healthy Adult Subjects. Antimicrobial Agents and Chemotherapy. PMID 33685898 DOI: 10.1128/AAC.02612-20  0.051
2018 Boyle C, Howard T, Griffith D, Cowie J. Primary meningococcal septic arthritis with multiple native joint involvement. Bmj Case Reports. 2018. PMID 29739760 DOI: 10.1136/bcr-2017-223197  0.05
2007 Watkins WJ, Chong L, Cho A, Hilgenkamp R, Ludwikow M, Garizi N, Iqbal N, Barnard J, Singh R, Madsen D, Lolans K, Lomovskaya O, Oza U, Kumaraswamy P, Blecken A, ... ... Griffith DC, et al. Quinazolinone fungal efflux pump inhibitors. Part 3: (N-methyl)piperazine variants and pharmacokinetic optimization. Bioorganic & Medicinal Chemistry Letters. 17: 2802-6. PMID 17350259 DOI: 10.1016/j.bmcl.2007.02.047  0.05
2020 van Ingen J, Aliberti S, Andrejak C, Chalmers JD, Codecasa LR, Daley CL, Hasegawa N, Griffith DE, Hoefsloot W, Huitt G, Jarand J, Jhun BW, Loebinger MR, Marras TK, Morimoto K, et al. Management of drug toxicity in M. avium complex pulmonary disease - an expert panel survey. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32910814 DOI: 10.1093/cid/ciaa1361  0.05
2021 Rubino CM, Onufrak NJ, van Ingen J, Griffith DE, Bhavnani SM, Yuen DW, Mange KC, Winthrop KL. Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease. European Journal of Drug Metabolism and Pharmacokinetics. PMID 33871806 DOI: 10.1007/s13318-021-00687-z  0.05
2017 Xu G, Yu W, Griffith D, Golmie N, Moulema P. Towards Integrating Distributed Energy Resources and Storage Devices in Smart Grid. Ieee Internet of Things Journal. 4: 192-204. PMID 29354654 DOI: 10.1109/JIOT.2016.2640563  0.05
2023 Griffith DC, Agwu AL. Uptake of PrEP for Youth…Progress not Perfection. Pediatrics. 152. PMID 37899726 DOI: 10.1542/peds.2023-063238  0.05
2015 Krupa A, Fol M, Dziadek BR, Kepka E, Wojciechowska D, Brzostek A, Torzewska A, Dziadek J, Baughman RP, Griffith D, Kurdowska AK. Binding of CXCL8/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune Response. Mediators of Inflammation. 2015: 124762. PMID 26300588 DOI: 10.1155/2015/124762  0.05
2015 Hoang HN, Song K, Hill TA, Derksen DR, Edmonds DJ, Kok WM, Limberakis C, Liras S, Loria PM, Mascitti V, Mathiowetz AM, Mitchell JM, Piotrowski DW, Price DA, Stanton RV, ... ... Griffith DA, et al. Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) Agonists. Journal of Medicinal Chemistry. 58: 4080-5. PMID 25839426 DOI: 10.1021/acs.jmedchem.5b00166  0.049
2017 Lodise TP, Fan W, Griffith DC, Dudley MN, Sulham KA. Coadministration of Minocycline with Colistin in Critically Ill Patients Is Associated with Reduced Frequency of Acute Renal Failure: A Retrospective Cohort Analysis. Antimicrobial Agents and Chemotherapy. PMID 29038261 DOI: 10.1128/Aac.01165-17  0.049
2023 Hernández-Mitre MP, Wallis SC, Morgan EE, Dudley MN, Loutit JS, Griffith DC, Roberts JA. A phase I, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the pharmacokinetics, safety, and tolerability of oral ceftibuten in healthy adult subjects. Antimicrobial Agents and Chemotherapy. e0109923. PMID 38059635 DOI: 10.1128/aac.01099-23  0.049
2019 Eden E, Choate R, Barker A, Addrizzo-Harris D, Aksamit TR, Daley CL, Daniels MLA, DiMango A, Fennelly K, Griffith DE, Johnson MM, Knowles MR, Metersky ML, Noone PG, O'Donnell AE, et al. The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research Registry. Chronic Obstructive Pulmonary Diseases (Miami, Fla.). 6. PMID 30974050 DOI: 10.15326/jcopdf.6.2.2018.0156  0.049
2015 Bandara N, Zheleznyak A, Cherukuri K, Griffith DA, Limberakis C, Tess DA, Jianqing C, Waterhouse R, Lapi SE. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 25987465 DOI: 10.1007/S11307-015-0861-5  0.048
2015 Kung DW, Griffith DA, Esler WP, Vajdos FF, Mathiowetz AM, Doran SD, Amor PA, Bagley SW, Banks T, Cabral S, Ford K, Garcia-Irizarry CN, Landis MS, Loomis K, McPherson K, et al. Discovery of spirocyclic-diamine inhibitors of mammalian acetyl CoA-carboxylase. Bioorganic & Medicinal Chemistry Letters. PMID 26411795 DOI: 10.1016/J.Bmcl.2015.09.035  0.048
2010 Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofalo RS, Griffith D, Griffor M, Loulakis P, Pabst B, Qiu X, Stockman B, Thanabal V, Varghese A, Ward J, et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. The Journal of Biological Chemistry. 285: 8340-51. PMID 20061378 DOI: 10.1074/Jbc.M109.088682  0.048
2022 Griffith DA, Edmonds DJ, Fortin JP, Kalgutkar AS, Kuzmiski JB, Loria PM, Saxena AR, Bagley SW, Buckeridge C, Curto JM, Derksen DR, Dias JM, Griffor MC, Han S, Jackson VM, et al. A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor. Journal of Medicinal Chemistry. PMID 35647711 DOI: 10.1021/acs.jmedchem.1c01856  0.048
2020 Seaton RA, Gibbons CL, Cooper L, Malcolm W, McKinney R, Dundas S, Griffith D, Jeffreys D, Hamilton K, Choo-Kang B, Brittain S, Guthrie D, Sneddon J. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals. The Journal of Infection. PMID 32987097 DOI: 10.1016/j.jinf.2020.09.024  0.047
2022 Griffith DE, Daley CL. Introducing the Nontuberculous Mycobacteria Series for CHEST. Chest. 161: 1-2. PMID 35000697 DOI: 10.1016/j.chest.2021.06.054  0.047
2023 Wolf AB, Money KM, Chandnani A, Daley CL, Griffith DE, Chauhan L, Coffman N, Piquet AL, Tyler KL, Zimmer SM, Montague BT, Mann S, Pastula DM. Mycobacterium abscessus Meningitis Associated with Stem Cell Treatment During Medical Tourism. Emerging Infectious Diseases. 29: 1655-1658. PMID 37486227 DOI: 10.3201/eid2908.230317  0.046
2020 Alghamdi WA, Al-Shaer MH, An G, Alsultan A, Kipiani M, Barbakadze K, Mikiashvili L, Ashkin D, Griffith DE, Cegielski JP, Kempker RR, Peloquin CA. Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimens Simulation and Target Attainment Analysis. Antimicrobial Agents and Chemotherapy. PMID 32778547 DOI: 10.1128/AAC.01174-20  0.046
2018 Kaye KS, Bhowmick T, Metallidis S, Bleasdale SC, Sagan OS, Stus V, Vazquez J, Zaitsev V, Bidair M, Chorvat E, Dragoescu PO, Fedosiuk E, Horcajada JP, Murta C, Sarychev Y, ... ... Griffith D, et al. Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial. Jama. 319: 788-799. PMID 29486041 DOI: 10.1001/jama.2018.0438  0.046
2016 Jao J, Fairlie L, Griffith D, Agwu AL. The Challenge of and Opportunities for Transitioning and Maintaining a Continuum of Care Among Adolescents and Young Adults Living with HIV in Resource Limited Settings. Current Tropical Medicine Reports. 3: 149-157. PMID 30854282 DOI: 10.1007/s40475-016-0091-1  0.046
2006 Carpino PA, Griffith DA, Sakya S, Dow RL, Black SC, Hadcock JR, Iredale PA, Scott DO, Fichtner MW, Rose CR, Day R, Dibrino J, Butler M, Debartolo DB, Dutcher D, et al. New bicyclic cannabinoid receptor-1 (CB1-R) antagonists. Bioorganic & Medicinal Chemistry Letters. 16: 731-6. PMID 16263283 DOI: 10.1016/j.bmcl.2005.10.019  0.046
2018 Mowbray NG, Griffith D, Hammoda M, Shingler G, Kambal A, Al-Sarireh B. A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. PMID 29336893 DOI: 10.1016/j.hpb.2017.12.009  0.045
2017 Lomovskaya O, Sun D, Rubio-Aparicio D, Nelson K, Tsivkovski R, Griffith DC, Dudley MN. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. PMID 28848018 DOI: 10.1128/AAC.01443-17  0.045
2021 Hurst EA, Mellanby RJ, Handel I, Griffith DM, Rossi AG, Walsh TS, Shankar-Hari M, Dunning J, Homer NZ, Denham SG, Devine K, Holloway PA, Moore SC, Thwaites RS, Samanta RJ, et al. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study. Bmj Open. 11: e055435. PMID 34686560 DOI: 10.1136/bmjopen-2021-055435  0.045
2022 Mirchandani AS, Jenkins SJ, Bain CC, Sanchez-Garcia MA, Lawson H, Coelho P, Murphy F, Griffith DM, Zhang A, Morrison T, Ly T, Arienti S, Sadiku P, Watts ER, Dickinson RS, et al. Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation. Nature Immunology. PMID 35624205 DOI: 10.1038/s41590-022-01216-z  0.045
2019 Griffith DE, Kronenberg RS. Chronic bronchitis. Postgraduate Medicine. 94: 93-100. PMID 29206549 DOI: 10.1080/00325481.1993.11945772  0.045
2007 Cao X, Liang L, Hadcock JR, Iredale PA, Griffith DA, Menniti FS, Factor S, Greenamyre JT, Papa SM. Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 323: 318-26. PMID 17630359 DOI: 10.1124/jpet.107.125666  0.044
2014 Hill TA, Lohman RJ, Hoang HN, Nielsen DS, Scully CC, Kok WM, Liu L, Lucke AJ, Stoermer MJ, Schroeder CI, Chaousis S, Colless B, Bernhardt PV, Edmonds DJ, Griffith DA, et al. Cyclic Penta- and Hexaleucine Peptides without N-Methylation Are Orally Absorbed. Acs Medicinal Chemistry Letters. 5: 1148-51. PMID 25313329 DOI: 10.1021/Ml5002823  0.044
2006 Garg A, Barnes PF, Porgador A, Roy S, Wu S, Nanda JS, Griffith DE, Girard WM, Rawal N, Shetty S, Vankayalapati R. Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. Journal of Immunology (Baltimore, Md. : 1950). 177: 6192-8. PMID 17056548  0.044
2017 Griffith DE, Philley JV. The new "Hesitation Blues": initiating Mycobacterium avium complex lung disease therapy. The European Respiratory Journal. 49. PMID 28275180 DOI: 10.1183/13993003.00110-2017  0.043
2009 Didiuk MT, Griffith DA, Benbow JW, Liu KK, Walker DP, Bi FC, Morris J, Guzman-Perez A, Gao H, Bechle BM, Kelley RM, Yang X, Dirico K, Ahmed S, Hungerford W, et al. Short-acting 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as orally-active calcium-sensing receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19: 4555-9. PMID 19625189 DOI: 10.1016/J.Bmcl.2009.07.004  0.043
2007 Griffith DE. Therapy of nontuberculous mycobacterial disease. Current Opinion in Infectious Diseases. 20: 198-203. PMID 17496580 DOI: 10.1097/QCO.0b013e328055d9a2  0.043
2018 Metersky ML, Aksamit TR, Barker A, Choate R, Daley CL, Daniels LA, DiMango A, Eden E, Griffith D, Johnson M, Knowles M, O'Donnell AE, Olivier K, Salathe M, Thomashow B, et al. The Prevalence and Significance of Staphylococcus aureus in Patients with non-Cystic Fibrosis Bronchiectasis. Annals of the American Thoracic Society. PMID 29345970 DOI: 10.1513/AnnalsATS.201706-426OC  0.042
2020 Sabet M, Tarazi Z, Griffith DC. In Vivo Activity of QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor, In Combination with Beta-Lactams Against Carbapenem-Resistant . Antimicrobial Agents and Chemotherapy. PMID 32839224 DOI: 10.1128/AAC.01267-20  0.042
2015 Bag R, Griffith DE. Therapy for Mycobacterium avium complex lung disease. It ain't perfect, but it's progress. American Journal of Respiratory and Critical Care Medicine. 191: 14-6. PMID 25551346 DOI: 10.1164/rccm.201411-2078ED  0.042
2021 Reddy KR, Parkinson J, Sabet M, Tarazi Z, Boyer SH, Lomovskaya O, Griffith DC, Hecker SJ, Dudley MN. Selection of QPX7831, an Orally Bioavailable Prodrug of Boronic Acid β-Lactamase Inhibitor QPX7728. Journal of Medicinal Chemistry. PMID 34817182 DOI: 10.1021/acs.jmedchem.1c01722  0.042
2016 Griffith DE, Aksamit TR. Nontuberculous Mycobacterial Disease Therapy: Take It to the Limit One More Time. Chest. 150: 1177-1178. PMID 27938739 DOI: 10.1016/j.chest.2016.07.015  0.041
2019 Goswami ND, Mase S, Griffith D, Bhavaraju R, Lardizabal A, Lauzardo M, Chen L, Wilson J, Chappelle C, Haley CA. Tuberculosis in the United States: Medical Consultation Services Provided by 5 Tuberculosis Regional Training and Medical Consultation Centers, 2013-2017. Open Forum Infectious Diseases. 6: ofz167. PMID 31205971 DOI: 10.1093/Ofid/Ofz167  0.041
2019 Philley JV, Kannan A, Olusola P, McGaha P, Singh KP, Samten B, Griffith DE, Dasgupta S. Microbiome Diversity in Sputum of Nontuberculous Mycobacteria Infected Women with a History of Breast Cancer. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 52: 263-279. PMID 30816674 DOI: 10.33594/000000020  0.041
2017 Griffith DC, Agwu AL. Caring for youth living with HIV across the continuum: turning gaps into opportunities. Aids Care. 1-7. PMID 28278569 DOI: 10.1080/09540121.2017.1290211  0.041
2012 Griffith DE, Winthrop KL. Mycobacterium avium complex lung disease therapy. American Journal of Respiratory and Critical Care Medicine. 186: 477-9. PMID 22984024 DOI: 10.1164/rccm.201207-1321ED  0.041
2018 Philley JV, Hertweck KL, Kannan A, Brown-Elliott BA, Wallace RJ, Kurdowska A, Ndetan H, Singh KP, Miller EJ, Griffith DE, Dasgupta S. Sputum Detection of Predisposing Genetic Mutations in Women with Pulmonary Nontuberculous Mycobacterial Disease. Scientific Reports. 8: 11336. PMID 30054559 DOI: 10.1038/S41598-018-29471-X  0.04
2005 Vankayalapati R, Garg A, Porgador A, Griffith DE, Klucar P, Safi H, Girard WM, Cosman D, Spies T, Barnes PF. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. Journal of Immunology (Baltimore, Md. : 1950). 175: 4611-7. PMID 16177106  0.039
2018 Pennington KM, Kennedy CC, Chandra S, Lauzardo M, Brito MO, Griffith DE, Seaworth BJ, Escalante P. Management and diagnosis of tuberculosis in solid organ transplant candidates and recipients: Expert survey and updated review. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 11: 37-46. PMID 31720390 DOI: 10.1016/j.jctube.2018.04.001  0.039
2016 Swedberg JE, Schroeder CI, Mitchell J, Fairlie DP, Edmonds DJ, Griffith DA, Ruggeri RB, Derksen DR, Loria PM, Price DA, Liras S, Craik DJ. Truncated glucagon-like peptide-1 and exendin-4 α-conotoxin pl14a peptide chimeras maintain potency, α-helicity and reveal interactions vital for cAMP signaling in vitro. The Journal of Biological Chemistry. PMID 27226591 DOI: 10.1074/Jbc.M116.724542  0.039
2015 Walker CA, Griffith DM, Gray AJ, Datta D, Hay AW. "Lactate Shift," Rather Than "Lactate Clearance," for Serial Blood Lactate Monitoring? Critical Care Medicine. 43: e596. PMID 26575681 DOI: 10.1097/CCM.0000000000001315  0.039
2019 Kronenberg RS, Griffith DE. Chronic bronchitis. Postgraduate Medicine. 94: 84-90. PMID 29206552 DOI: 10.1080/00325481.1993.11945771  0.038
2016 Plisson F, Hill TA, Mitchell JM, Hoang HN, de Araujo AD, Xu W, Cotterell A, Edmonds DJ, Stanton RV, Derksen DR, Loria PM, Griffith DA, Price DA, Liras S, Fairlie DP. Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling. European Journal of Medicinal Chemistry. PMID 27823886 DOI: 10.1016/j.ejmech.2016.10.044  0.038
2016 Griffith D, Farmer C, Rutstein R, Mathews WC, Beil R, Korthuis PT, Berry S, Nijhawan AE, Gaur A, Gebo K, Agwu A. Uptake and Virologic Outcomes of One-pill versus Multi-pill Antiretroviral Therapy Among Treatment-naïve Non-perinatally HIV-infected Youth (2006-2014) Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1245  0.038
2022 Kumar K, Daley CL, Griffith DE, Loebinger MR. Management of complex and pulmonary disease: therapeutic advances and emerging treatments. European Respiratory Review : An Official Journal of the European Respiratory Society. 31. PMID 35140106 DOI: 10.1183/16000617.0212-2021  0.038
2023 Limberakis C, Smith AC, Bagley SW, Yayla HG, Kung DW, Griffith DA. Convergent Syntheses of Isomeric Imidazolospiroketones as Templates for Acetyl-CoA Carboxylase (ACC) Inhibitors. The Journal of Organic Chemistry. PMID 37751412 DOI: 10.1021/acs.joc.3c01374  0.037
2019 Harris AJ, Mirchandani AS, Lynch RW, Murphy F, Delaney L, Small D, Coelho P, Watts ER, Sadiku P, Griffith D, Dickinson RS, Clark E, Willson JA, Morrison T, Mazzone M, et al. IL4Rα Signaling Abrogates Hypoxic Neutrophil Survival and Limits Acute Lung Injury Responses In Vivo. American Journal of Respiratory and Critical Care Medicine. PMID 30849228 DOI: 10.1164/rccm.201808-1599OC  0.037
2019 Jones JRA, Berney S, Connolly B, Waterland JL, Denehy L, Griffith DM, Puthucheary ZA. Socioeconomic Position and Health Outcomes Following Critical Illness: A Systematic Review. Critical Care Medicine. PMID 30920412 DOI: 10.1097/CCM.0000000000003727  0.037
2018 Al-Sarireh B, Mowbray NG, Al-Sarira A, Griffith D, Brown TH, Wells T. Can infected pancreatic necrosis really be managed conservatively? European Journal of Gastroenterology & Hepatology. PMID 30148805 DOI: 10.1097/MEG.0000000000001231  0.037
2023 Xu H, Liu X, Yu W, Griffith D, Golmie N. Reinforcement Learning-Based Control and Networking Co-design for Industrial Internet of Things. Ieee Journal On Selected Areas in Communications : a Publication of the Ieee Communications Society. 38. PMID 37555009 DOI: 10.1109/jsac.2020.2980909  0.037
2016 Smith AC, Cabral S, Kung DW, Rose CR, Southers JA, Garcia-Irizarry CN, Damon DB, Bagley SW, Griffith DA. The synthesis of methyl-substituted spirocyclic piperidine-azetidine (2,7-diazaspiro[3.5]nonane) and spirocyclic piperidine-pyrrolidine (2,8-diazaspiro[4.5]decane) ring systems. The Journal of Organic Chemistry. PMID 27056793 DOI: 10.1021/Acs.Joc.5B02890  0.036
2022 Bai X, Bai A, Tomasicchio M, Hagman JR, Buckle AM, Gupta A, Kadiyala V, Bevers S, Serban KA, Kim K, Feng Z, Spendier K, Hagen G, Fornis L, Griffith DE, et al. α1-Antitrypsin Binds to the Glucocorticoid Receptor with Anti-Inflammatory and Antimycobacterial Significance in Macrophages. Journal of Immunology (Baltimore, Md. : 1950). PMID 36162872 DOI: 10.4049/jimmunol.2200227  0.036
2014 Griffith D, Rubino C, Loutit J, Morgan E, White D, Dudley M. 401A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of the Beta-lactamase inhibitor RPX7009 Alone, Meropenem Alone, and both in Combination (Carbavance) TID for 7 days in Healthy Adult Subjects Open Forum Infectious Diseases. 1: S154-S155. DOI: 10.1093/Ofid/Ofu052.267  0.036
2021 Shah A, Chester-Jones M, Dutton SJ, Marian IR, Barber VS, Griffith DM, Singleton J, Wray K, James T, Drakesmith H, Robbins PA, Frise MC, Young JD, Walsh TS, McKechnie SR, et al. Intravenous iron to treat anaemia following critical care: a multicentre feasibility randomised trial. British Journal of Anaesthesia. PMID 34872717 DOI: 10.1016/j.bja.2021.11.010  0.035
2016 Lomovskaya O, Nelson K, Rubio-Aparicio D, Sun D, Griffith D, Dudley MN. Minocycline (MINO) Activity Is Enhanced by Polymyxin B (PmB) in TetB Containing Isolates of Acinetobacter baumannii (ACB), Including Those Resistant to PmB Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1589  0.035
2020 Armbruster M, Fields EL, Campbell N, Griffith DC, Kouoh AM, Knott-Grasso MA, Arrington-Sanders R, Agwu AL. Addressing Health Inequities Exacerbated by COVID-19 Among Youth With HIV: Expanding Our Toolkit. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. PMID 32527573 DOI: 10.1016/j.jadohealth.2020.05.021  0.034
2022 Griffith DM, Walsh TS. Outcomes from COVID-19 Clinical Trials in Hospitalised Patients: Seeking the Truth that Matters. American Journal of Respiratory and Critical Care Medicine. PMID 35608532 DOI: 10.1164/rccm.202205-0907ED  0.034
2003 Renau TE, Léger R, Filonova L, Flamme EM, Wang M, Yen R, Madsen D, Griffith D, Chamberland S, Dudley MN, Lee VJ, Lomovskaya O, Watkins WJ, Ohta T, Nakayama K, et al. Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorganic & Medicinal Chemistry Letters. 13: 2755-8. PMID 12873508 DOI: 10.1016/S0960-894X(03)00556-0  0.033
2017 Ambrose PG, Lomovskaya O, Griffith DC, Dudley MN, VanScoy B. β-Lactamase inhibitors: what you really need to know. Current Opinion in Pharmacology. 36: 86-93. PMID 29096172 DOI: 10.1016/j.coph.2017.09.001  0.033
2018 van Ingen J, Aksamit T, Andrejak C, Böttger EC, Cambau E, Daley CL, Griffith DE, Guglielmetti L, Holland SM, Huitt GA, Koh WJ, Lange C, Leitman P, Marras TK, Morimoto K, et al. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. The European Respiratory Journal. 51. PMID 29567726 DOI: 10.1183/13993003.00170-2018  0.033
2014 Griffith DE. Testing for latent tuberculosis. Applying the best of intentions. Annals of the American Thoracic Society. 11: 594-5. PMID 24828801 DOI: 10.1513/AnnalsATS.201403-130ED  0.033
2010 Griffith DE. Nontuberculous mycobacterial lung disease. Current Opinion in Infectious Diseases. 23: 185-90. PMID 20087178 DOI: 10.1097/QCO.0b013e328336ead6  0.033
2020 Griffith DE, Marras T. Nontuberculous mycobacterial disease epidemiology: You can see the stars and still not see the light. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32756945 DOI: 10.1093/cid/ciaa1096  0.033
2015 Lomovskaya O, Griffith D, Loutit J, Dudley M. Rationale for Dose Selection for Carbavance ([CVC] Meropenem/RPX7009) in Phase 3 Trials Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.511  0.033
2014 Griffith DE. Reply: Latent tuberculosis infection among foreign-born persons: a prioritized approach. Annals of the American Thoracic Society. 11: 1336. PMID 25343204 DOI: 10.1513/AnnalsATS.201408-382LE  0.032
2009 Paidipally P, Periasamy S, Barnes PF, Dhiman R, Indramohan M, Griffith DE, Cosman D, Vankayalapati R. NKG2D-dependent IL-17 production by human T cells in response to an intracellular pathogen. Journal of Immunology (Baltimore, Md. : 1950). 183: 1940-5. PMID 19587005 DOI: 10.4049/jimmunol.0803578  0.032
2006 Doppalapudi VR, Tryder N, Li L, Aja T, Griffith D, Liao FF, Roxas G, Ramprasad MP, Bradshaw C, Barbas CF. Chemically programmed antibodies: endothelin receptor targeting CovX-Bodies. Bioorganic & Medicinal Chemistry Letters. 17: 501-6. PMID 17055724 DOI: 10.1016/j.bmcl.2006.10.009  0.032
2023 Litton E, French C, Herschtal A, Stanworth S, Pellicano S, Palermo AM, Bates S, Van Der Laan S, Eroglu E, Griffith D, Shah A. Iron and erythropoietin to heal and recover after intensive care (ITHRIVE): A pilot randomised clinical trial. Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine. 25: 201-206. PMID 38236513 DOI: 10.1016/j.ccrj.2023.10.007  0.032
2017 Griffith DM, Salisbury L, Lee RJ, Lone N, Merriweather JL, Walsh T. The Burden of Specific Symptoms Reported by Survivors After Critical Illness. American Journal of Respiratory and Critical Care Medicine. PMID 28650202 DOI: 10.1164/rccm.201702-0398LE  0.031
2018 Griffith DM. Body Composition After Critical Illness: Fat in All the Wrong Places? Critical Care Medicine. 46: 1376-1377. PMID 30004969 DOI: 10.1097/CCM.0000000000003234  0.031
2009 Griffith D, Miles B. Exploding masks--universal connectors in emergency airway equipment. Resuscitation. 80: 1090. PMID 19586704 DOI: 10.1016/j.resuscitation.2009.05.022  0.031
2023 Bai X, Verma D, Garcia C, Musheyev A, Kim K, Fornis L, Griffith DE, Li L, Whittel N, Gadwa J, Ohanjanyan T, Eggleston MJ, Galvan M, Freed BM, Ordway D, et al. and evidence that cigarette smoke-exposed T regulatory cells impair host immunity against . Frontiers in Cellular and Infection Microbiology. 13: 1216492. PMID 37965256 DOI: 10.3389/fcimb.2023.1216492  0.03
2018 Griffith DE, Aksamit TR. Mycobacterium Avium Complex and Bronchiectasis: There's Something Happening Here…. American Journal of Respiratory and Critical Care Medicine. PMID 30092144 DOI: 10.1164/rccm.201807-1243ED  0.03
2018 Griffith DE, Aksamit TR. Mycobacterium Avium Complex and Bronchiectasis: There's Something Happening Here…. American Journal of Respiratory and Critical Care Medicine. PMID 30092144 DOI: 10.1164/rccm.201807-1243ED  0.03
2016 Griffith DE. Macrolide-Resistant Mycobacterium avium Complex: "I Feel Like I've Been Here Before". Annals of the American Thoracic Society. 13: 1881-1882. PMID 27831800 DOI: 10.1513/AnnalsATS.201609-666ED  0.03
2009 Griffith DA, Hadcock JR, Black SC, Iredale PA, Carpino PA, DaSilva-Jardine P, Day R, DiBrino J, Dow RL, Landis MS, O'Connor RE, Scott DO. Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist. Journal of Medicinal Chemistry. 52: 234-7. PMID 19102698 DOI: 10.1021/jm8012932  0.03
2003 Shams H, Wizel B, Lakey DL, Samten B, Vankayalapati R, Valdivia RH, Kitchens RL, Griffith DE, Barnes PF. The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocytes. Fems Immunology and Medical Microbiology. 36: 63-9. PMID 12727367 DOI: 10.1016/S0928-8244(03)00039-7  0.03
2018 Griffith D, Hanna T, Wong K, Reece-Smith A, Aroori S, Bowles M, Stell D, Briggs C. Comparison of lipase and amylase for diagnosing post-operative pancreatic fistulae. Anz Journal of Surgery. PMID 29882290 DOI: 10.1111/ans.14266  0.029
2020 Yusuf H, Fields E, Arrington-Sanders R, Griffith D, Agwu AL. HIV Preexposure Prophylaxis Among Adolescents in the US: A Review. Jama Pediatrics. PMID 32391878 DOI: 10.1001/jamapediatrics.2020.0824  0.029
2014 Nolte WM, Fortin JP, Stevens BD, Aspnes GE, Griffith DA, Hoth LR, Ruggeri RB, Mathiowetz AM, Limberakis C, Hepworth D, Carpino PA. A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification. Nature Chemical Biology. 10: 629-31. PMID 24997604 DOI: 10.1038/Nchembio.1581  0.029
2007 Griffith D, Bellows B, Potts M. Cut to the chase: quickly achieving high coverage male circumcision. Journal of Epidemiology and Community Health. 61: 612. PMID 17568053  0.029
2021 Ku JH, Siegel SA, Philley J, Schipper P, Thanawala R, Hendrick MA, Sigler C, Strnad L, McShane P, Griffith D, Tieu B, Caccitolo J, Fuss C, Le A, Winthrop K. Outcomes of Resectional Thoracic Surgery for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease in 105 U.S. Patients. Chest. PMID 34390707 DOI: 10.1016/j.chest.2021.08.004  0.028
2015 Griffith DE. Nontuberculous Mycobacterial Disease Research. An End to the Beginning. American Journal of Respiratory and Critical Care Medicine. 192: 535-7. PMID 26325154 DOI: 10.1164/rccm.201506-1090ED  0.028
2017 Griffith DC, Aronis KN, Orozco AM, Traill TA, Manabe YC, Agwu AL. Premature Coronary Artery Disease and ST-Elevation Myocardial Infarction in a 24-Year-Old Man With Perinatally Acquired Human Immunodeficiency Virus: A Case Report. Open Forum Infectious Diseases. 4: ofw260. PMID 28480253 DOI: 10.1093/ofid/ofw260  0.028
2018 Griffith D, Snyder J, Dell S, Nolan K, Keruly J, Agwu A. Impact of a youth-focused care model on retention and virologic suppression among young adults with HIV cared for in an adult HIV clinic. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30422910 DOI: 10.1097/QAI.0000000000001902  0.027
2018 Shah A, Wray K, James T, Shine B, Morovat R, Stanworth S, McKechnie S, Kirkbride R, Griffith DM, Walsh TS, Drakesmith H, Roy N. Serum hepcidin potentially identifies iron deficiency in survivors of critical illness at the time of hospital discharge. British Journal of Haematology. PMID 29363744 DOI: 10.1111/bjh.15067  0.027
2022 Mirchandani AS, Jenkins SJ, Bain CC, Sanchez-Garcia MA, Lawson H, Coelho P, Murphy F, Griffith DM, Zhang A, Morrison T, Ly T, Arienti S, Sadiku P, Watts ER, Dickinson RS, et al. Author Correction: Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation. Nature Immunology. PMID 35854097 DOI: 10.1038/s41590-022-01286-z  0.025
2007 Griffith D. Assisted dying. Clinical Medicine (London, England). 6: 510. PMID 17080905 DOI: 10.7861/clinmedicine.6-5-510  0.024
2021 Shah A, Marian I, Dutton SJ, Barber VS, Griffith DM, McKechnie S, Chapman G, Robbins PA, Duncan Young J, Walsh T, Stanworth SJ. INtravenous iron to treat anaemia following CriTical care (INTACT): A protocol for a feasibility randomised controlled trial. Journal of the Intensive Care Society. 22: 182. PMID 34025758 DOI: 10.1177/17511437211012163  0.024
2016 Aksamit TR, O'Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels ML, Johnson M, Eden E, Griffith D, Knowles M, Metersky M, Salathe M, Thomashow B, Tino G, Turino G, et al. Adult Bronchiectasis Patients: A First Look at the United States Bronchiectasis Research Registry. Chest. PMID 27889361 DOI: 10.1016/j.chest.2016.10.055  0.024
2013 Griffith D. Conflicts of interest of clinicians associated with document on collaboration between doctors and drug industry still being sought. Bmj (Clinical Research Ed.). 346: f1188. PMID 23444436  0.024
2022 Yusuf HE, Griffith D, Agwu AL. Preventing and diagnosing HIV-related comorbidities in adolescents. Topics in Antiviral Medicine. 30: 537-544. PMID 36347060  0.024
2018 Griffith DE. Treatment of Mycobacterium avium Complex (MAC). Seminars in Respiratory and Critical Care Medicine. 39: 351-361. PMID 30071550 DOI: 10.1055/s-0038-1660472  0.023
2016 van Ingen J, Wagner D, Gallagher J, Morimoto K, Lange C, Haworth CS, Floto RA, Adjemian J, Prevots DR, Griffith DE. Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases. The European Respiratory Journal. PMID 28182571 DOI: 10.1183/13993003.01855-2016  0.023
2004 Griffith DE. Treatment of multidrug-resistant tuberculosis: should you try this at home? American Journal of Respiratory and Critical Care Medicine. 169: 1082-3. PMID 15132956 DOI: 10.1164/rccm.2403003  0.022
2019 Griffith D, Jin L, Childs J, Posada R, Jao J, Agwu A. Outcomes of a Comprehensive Retention Strategy for Youth With HIV After Transfer to Adult Care in the United States. The Pediatric Infectious Disease Journal. PMID 30985513 DOI: 10.1097/INF.0000000000002309  0.022
2010 Griffith DE, Stout JE. It is better to light a candle ... than to repeat the opinions of experts. American Journal of Respiratory and Critical Care Medicine. 182: 865-6. PMID 20884939 DOI: 10.1164/rccm.201008-1251ED  0.021
2007 Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine. 175: 367-416. PMID 17277290 DOI: 10.1164/rccm.200604-571ST  0.021
2007 Winthrop KL, Daley CL, Griffith D. Nontuberculous mycobacterial disease: Updated diagnostic criteria for an under-recognized infectious complication of anti-tumor necrosis factor therapy Nature Clinical Practice Rheumatology. 3. PMID 17906608 DOI: 10.1038/ncprheum0621  0.021
2015 Winthrop KL, Ku JH, Marras TK, Griffith DE, Daley CL, Olivier KN, Aksamit TR, Varley CD, Mackey K, Prevots DR. The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease. The European Respiratory Journal. 45: 1177-9. PMID 25614169 DOI: 10.1183/09031936.00169114  0.021
2014 Cegielski JP, Griffith DE, McGaha PK, Wolfgang M, Robinson CB, Clark PA, Hassell WL, Robison VA, Walker KP, Wallace C. Eliminating tuberculosis one neighborhood at a time. American Journal of Public Health. 104: S214-33. PMID 24899457 DOI: 10.2105/AJPH.2012.300781r  0.02
2013 Cegielski JP, Griffith DE, McGaha PK, Wolfgang M, Robinson CB, Clark PA, Hassell WL, Robison VA, Walker KP, Wallace C. [Eliminating tuberculosis one neighborhood at a time]. Revista Panamericana De Salud PúBlica = Pan American Journal of Public Health. 34: 284-94. PMID 24301742  0.02
2013 Cegielski JP, Griffith DE, McGaha PK, Wolfgang M, Robinson CB, Clark PA, Hassell WL, Robison VA, Walker KP, Wallace C. Eliminating tuberculosis one neighborhood at a time. American Journal of Public Health. 103: 1292-300. PMID 23078465 DOI: 10.2105/AJPH.2012.300781  0.02
2017 Tortoli E, Kohl TA, Brown-Elliott BA, Trovato A, Cardoso-Leão S, Garcia MJ, Vasireddy S, Turenne CY, Griffith DE, Philley JV, Niemann S, Wallace RJ, Cirillo DM. Mycobacterium abscessus, a taxonomic puzzle. International Journal of Systematic and Evolutionary Microbiology. PMID 29139343 DOI: 10.1099/ijsem.0.002457  0.02
2019 Griffith DE. Mycobacterium abscessus and antibiotic resistance: Same as it ever was. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30689764 DOI: 10.1093/cid/ciz071  0.02
2013 Fennelly KP, Griffith DE. Azithromycin in non-cystic-fibrosis bronchiectasis. Lancet (London, England). 381: 27. PMID 23290963 DOI: 10.1016/S0140-6736(13)60013-6  0.02
2011 Griffith DM, Walsh TS. Bone loss during critical illness: A skeleton in the closet for the intensive care unit survivor? Critical Care Medicine. 39: 1554-1556. PMID 21610619 DOI: 10.1097/CCM.0b013e318215beb4  0.019
2022 Khoo CH, Raimes S, Griffith D. Colonic gastro-intestinal stromal tumours: a rare cause of gastro-intestinal bleeding. Anz Journal of Surgery. PMID 35076158 DOI: 10.1111/ans.17487  0.018
2011 Griffith DE. The talking Mycobacterium abscessus blues. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 572-4. PMID 21292660 DOI: 10.1093/cid/ciq252  0.018
2011 Miao Z, Scott DO, Griffith DA, Day R, Prakash C. Excretion, metabolism, and pharmacokinetics of CP-945,598, a selective cannabinoid receptor antagonist, in rats, mice, and dogs. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 2191-208. PMID 21875952 DOI: 10.1124/dmd.111.040360  0.016
2015 Griffith DC, Adler D, Wallace M, Bennie T, Abar B, Bekker LG. Knowledge of HPV among HIV-Infected and HIV-Uninfected Adolescent Women in South Africa. Journal of Women's Health, Issues & Care. 4. PMID 26925426 DOI: 10.4172/2325-9795.1000203  0.015
2015 Griffith DE, Brown-Elliott BA, Wallace RJ. Hit the Road, MAC, and Don't You Come Back No More. American Journal of Respiratory and Critical Care Medicine. 191: 1222-4. PMID 26029835 DOI: 10.1164/rccm.201504-0774ED  0.013
2019 Pellegrino R, Griffith D, Agwu A. 190. Patterns of Retention In HIV Care And Factors Associated With Viral Suppression In Youth And Young Adults Age 18-30 With HIV In An Urban Practice Journal of Adolescent Health. 64. DOI: 10.1016/J.Jadohealth.2018.10.207  0.013
2006 Griffith DE. If it isn't something, it's something else... Southern Medical Journal. 99: 112-3. PMID 16509546 DOI: 10.1097/01.smj.0000198263.44417.ea  0.013
2020 Griffith DE, Cegielski JP. Tuberculosis Healthcare Workers: There Goes My Hero. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32502233 DOI: 10.1093/cid/ciaa716  0.012
2003 Griffith DE. Emergence of nontuberculous mycobacteria as pathogens in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 167: 810-2. PMID 12623856 DOI: 10.1164/rccm.2301001  0.012
2019 Griffith D. Letters to the Editor. Journal of the Royal College of Physicians of London. 31: 469. PMID 30668047  0.01
2017 Ruffner MA, Aksamit TR, Thomashow B, Choate R, DiMango A, Turino GM, O'Donnell AE, Johnson MM, Olivier KN, Fennelly K, Daley CL, Winthrop KL, Metersky ML, Salathe MA, Knowles MR, ... ... Griffith DE, et al. Frequency of untreated hypogammaglobulinemia in bronchiectasis. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. PMID 28539185 DOI: 10.1016/j.anai.2017.04.020  0.01
2015 Philley JV, Griffith DE. Impulse Oscillometry and Bronchiectasis. We Still Haven't Found What We're Looking For? Annals of the American Thoracic Society. 12: 621-2. PMID 25965535 DOI: 10.1513/AnnalsATS.201502-100ED  0.01
2013 Griffith D. Only one handed applause due. Bmj (Clinical Research Ed.). 346: f1954. PMID 23550072  0.01
2009 Dow RL, Hadcock JR, Scott DO, Schneider SR, Paight ES, Iredale PA, Carpino PA, Griffith DA, Hammond M, Dasilva-Jardine P. Bioisosteric replacement of the hydrazide pharmacophore of the cannabinoid-1 receptor antagonist SR141716A. Part I: potent, orally-active 1,4-disubstituted imidazoles. Bioorganic & Medicinal Chemistry Letters. 19: 5351-4. PMID 19683918 DOI: 10.1016/j.bmcl.2009.07.130  0.01
2006 Burke WA, Griffith DC, Scott CM, Howell ER. Skin problems related to the occupation of commercial fishing in North Carolina. North Carolina Medical Journal. 67: 260-5. PMID 17066654  0.01
Hide low-probability matches.